rfhg_207658.1

Basic information about the TSS

---

TSS ID: rfhg_207658.1 TSS ID(Version3): hg_173884.1 hg_173883.1 Species: human Chr: chr19		Start: 10960977 End: 10961122 Strand: +
Source datasets	FANTOM5|DRA000914|DRA013844|PRJNA548673|PRJNA615891 |PRJNA401781|PRJNA4843412
Protocol	CAGE|ReCappable-seq|TIF-seq2|SLIC_CAGE|NETCAGE
TSS cluster detected*	8

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000646510.1:0 ENST00000429416.8:0 ENST00000644760.1:0 ENST00000344626.10:0 ENST00000646693.2:0 ENST00000645460.1:0 ENST00000541122.6:0 ENST00000589677.5:0 ENST00000444061.8:0 BC150298:0 AK290033:0 BC139917:0 BC139924:0 BC007302:0 BC035916:0 GeneID: 6597 HGNC/MGI_ID: HGNC:11100 UniProt_ID: A0A2R8Y866 A7E2E1 P51532 Q9HBD4 Nearer transcript ids and distances: U29175:10 ENST00000642628.1:-20 ENST00000643296.1:-20 ENST00000647230.1:-20 D26156:27 ENST00000643549.1:-45 ENST00000642726.1:-45 ENST00000646484.1:-45 ENST00000644737.1:-45 LP955720:-55 MB474734:-55 ENST00000590574.6:199 view more...

Gene_name: SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4 Gene_symbol: SMARCA4 Gene_synonyms: BAF190 BRG1 FLJ39786 SNF2 SNF2-BETA SNF2LB SWI2 hSNF2b Gene_source: HGNC:11100

TATA-Box annotation

---

Distance to TSS:	19
Nearest PromoterID:	NM_001128847
Entrez ID:	6597
Nearest Unigene:	Hs.327527
Nearest Refseq:	NM_003072
Nearest Ensembl:	ENSG00000127616
Gene Name:	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4
Gene Alias:	BAF190|BAF190A|BRG1|CSS4|MRD16|RTPS2|SNF2|SNF2L4|SNF2LB|SWI2|hSNF2b
Gene Type:	protein-coding
CpG%:	0.158621
GC%:	0.753425
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@SMARCA4 p2@SMARCA4 p3@SMARCA4 p4@SMARCA4 p5@SMARCA4 p6@SMARCA4 p7@SMARCA4 p8@SMARCA4 p9@SMARCA4 p10@SMARCA4
Sample		p1@SMARCA4	p2@SMARCA4	p3@SMARCA4	p4@SMARCA4	p5@SMARCA4	p6@SMARCA4	p7@SMARCA4	p8@SMARCA4	p9@SMARCA4	p10@SMARCA4
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	56.88	5.26	3.51	0.39	0.19	0.00	0.19	0.19	0.39	1.17
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	60.70	5.06	3.64	0.40	0.81	0.00	0.61	0.61	0.20	0.20
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	56.71	3.47	2.89	0.77	0.19	0.39	0.39	0.00	0.00	0.58
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	48.65	2.70	2.49	0.83	0.62	0.00	0.42	1.04	0.00	0.62
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	51.74	2.70	5.17	1.35	1.35	0.22	0.22	0.22	0.22	0.45
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	51.17	4.07	2.91	0.78	0.39	0.39	0.19	0.39	0.39	0.58
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	60.35	3.70	3.49	1.09	0.00	0.65	0.44	0.87	0.22	0.65
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	64.91	4.60	2.18	1.70	0.97	0.00	0.73	0.97	0.24	0.73
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	69.67	4.06	3.85	0.85	0.85	0.00	0.00	1.28	0.43	0.00
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	60.28	9.85	1.74	1.74	2.90	0.58	0.00	2.90	0.00	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	67.91	8.08	1.62	0.81	1.62	1.62	0.81	0.40	0.40	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	73.99	8.13	2.85	2.44	1.63	0.41	0.00	0.81	0.41	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	28.85	4.35	2.74	0.64	4.51	0.32	0.16	0.48	0.00	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	18.64	2.26	1.95	0.30	2.56	0.45	0.15	0.30	0.15	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	19.32	3.07	2.63	0.22	1.76	0.00	0.44	0.22	0.00	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	20.62	2.51	1.76	0.00	2.51	0.75	0.00	1.51	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	14.85	2.18	2.62	0.44	2.62	0.44	0.22	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	15.19	1.69	1.27	0.42	1.27	0.42	0.00	2.11	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	16.53	2.13	1.07	0.00	2.67	0.53	0.00	0.53	0.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	21.36	2.11	2.71	0.30	2.11	0.15	0.45	0.45	0.45	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	21.52	4.41	2.14	0.40	2.27	0.13	0.13	0.40	0.27	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	19.33	1.73	2.42	0.17	2.59	0.35	0.17	0.17	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	18.10	3.36	2.59	0.26	2.46	0.13	0.13	0.39	0.39	0.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	15.29	3.40	1.46	0.49	1.94	0.49	0.00	0.73	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	25.80	1.55	1.55	0.77	3.61	0.26	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	22.16	0.63	3.48	0.32	0.95	0.32	0.00	0.00	0.32	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	25.82	1.10	2.20	0.00	3.30	1.10	0.00	0.55	0.00	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	27.11	3.06	4.01	0.24	2.12	0.24	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	20.03	3.07	2.26	0.81	2.75	0.32	0.16	0.16	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	18.28	3.80	1.45	0.72	1.99	0.18	0.54	0.54	0.00	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	18.84	3.35	1.67	0.63	1.47	0.21	0.21	0.21	0.42	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	19.15	3.13	2.34	0.39	2.93	0.20	0.20	0.59	0.39	0.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	22.16	4.22	1.48	0.84	2.32	0.21	0.21	0.21	0.21	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	13.69	2.14	1.48	0.33	0.49	0.16	0.16	0.99	0.33	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	18.51	2.99	1.50	0.37	1.68	0.56	0.37	0.37	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	17.25	2.87	1.92	0.00	1.53	0.19	0.00	0.38	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	18.19	3.88	2.86	0.41	1.43	0.20	0.00	0.20	0.61	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	17.93	3.02	1.21	0.20	2.22	0.60	0.20	0.60	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	14.32	3.51	2.43	0.54	3.24	0.00	0.00	0.54	0.00	0.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	17.52	1.68	1.20	0.24	1.20	0.24	0.00	0.96	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	17.17	3.53	2.35	0.47	2.59	0.00	0.24	0.00	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	13.76	2.20	1.46	0.29	1.32	0.29	0.15	0.59	0.00	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	16.24	4.22	2.74	0.21	2.95	0.21	0.00	1.27	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	20.45	3.67	1.05	0.17	2.62	0.52	0.00	0.52	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	19.47	3.41	3.41	0.00	3.01	0.40	0.20	0.20	0.00	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	17.68	2.56	0.93	0.47	2.33	0.23	0.47	0.70	0.70	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	20.63	4.32	2.40	0.24	2.64	0.48	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	21.16	2.98	1.19	0.00	2.09	0.30	0.89	0.30	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	21.30	2.63	2.15	0.72	1.91	0.24	0.48	0.24	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	21.23	3.03	2.22	0.40	1.82	0.20	0.00	0.40	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	20.91	4.51	2.46	0.20	2.66	0.20	0.00	0.61	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	24.68	4.45	1.11	0.44	1.33	0.67	0.22	0.44	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	13.99	0.00	0.00	0.00	0.00	13.99	13.99	0.00	0.00	13.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	24.49	1.06	0.35	0.00	2.84	0.35	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	23.20	2.65	1.66	0.66	1.99	0.00	0.00	0.33	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	7.55	0.00	0.84	0.00	1.68	0.00	0.00	0.84	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	13.32	1.84	0.92	0.00	0.92	0.00	0.00	0.46	0.92	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	27.87	3.57	3.57	0.97	2.59	0.00	0.00	0.32	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	25.05	1.61	1.28	0.00	3.53	0.00	0.00	0.32	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	20.12	2.83	1.57	0.31	0.94	0.00	0.63	0.31	0.63	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	29.61	0.71	2.82	0.00	2.82	1.41	0.71	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	25.24	1.68	2.80	0.56	0.00	0.00	0.56	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	21.50	3.18	1.59	0.00	0.00	1.59	1.59	0.00	0.80	2.39
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	23.44	3.06	1.70	0.00	1.36	0.00	1.36	0.00	0.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	30.54	2.60	2.92	0.00	1.95	0.00	0.32	0.65	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	31.24	2.13	2.13	1.06	1.77	0.35	0.35	1.06	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	15.79	7.90	0.00	0.00	0.00	0.00	0.00	0.00	7.90	7.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	28.76	1.95	1.46	0.00	0.49	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	21.82	1.98	2.48	0.50	0.50	0.00	0.00	0.50	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	21.58	1.88	0.47	0.00	2.35	0.47	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	20.53	2.32	1.99	0.00	1.66	0.00	0.33	0.33	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	21.04	0.93	1.24	0.00	2.17	0.00	0.62	0.93	0.31	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	26.91	1.83	1.53	0.61	3.67	0.00	0.00	0.00	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	8.24	3.33	0.95	0.00	0.79	0.48	0.00	0.48	0.00	0.16
Adipocyte - breast, donor2	11327-117E4	11.07	2.41	1.93	0.16	0.48	0.16	0.80	0.32	0.48	0.16
Adipocyte - omental, donor1	11473-119C6	9.03	4.58	1.02	0.00	0.76	0.00	0.13	0.38	0.00	0.00
Adipocyte - omental, donor2	11474-119C7	8.22	0.75	4.48	0.00	1.49	0.00	0.75	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	9.04	3.01	2.68	1.00	1.00	0.00	0.00	0.67	0.00	0.00
Adipocyte - perirenal, donor1	11476-119C9	8.29	1.28	1.28	0.00	1.28	0.00	0.00	0.64	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	3.30	2.20	0.00	0.00	1.10	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	14.45	2.71	0.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor3	11408-118E4	7.65	2.43	1.56	0.35	1.04	0.17	0.00	0.17	0.00	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	25.62	4.50	3.91	0.59	0.39	0.20	0.20	0.39	0.00	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	22.91	3.60	2.32	0.51	0.51	0.00	0.00	0.00	0.00	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	19.24	4.18	2.79	0.00	1.95	0.00	0.28	0.00	0.28	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	10.58	5.29	0.59	0.00	0.00	0.59	0.00	0.59	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	18.82	3.70	3.78	0.64	1.13	0.40	0.16	0.56	0.08	0.00
Adipocyte differentiation, day08, donor2	13023-139D8	15.17	2.90	1.29	0.32	0.32	0.00	0.32	0.00	0.32	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	6.93	1.07	0.00	0.00	2.13	0.53	0.00	0.00	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	15.02	1.11	0.56	0.56	0.00	0.00	0.00	0.00	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	11.64	1.66	2.08	0.42	1.25	0.00	0.42	0.00	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	9.29	3.52	0.75	0.50	1.00	0.00	0.00	0.25	0.25	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	13.09	3.27	0.00	0.33	0.65	0.65	0.00	0.33	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	12.18	2.13	0.91	0.30	0.61	0.00	0.00	0.00	0.30	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	48.62	3.31	4.64	1.33	0.44	0.00	0.44	0.22	0.00	0.22
Alveolar Epithelial Cells, donor2	11590-120G6	50.56	2.87	2.51	0.72	0.36	0.36	1.08	0.36	0.36	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	20.37	2.40	0.00	0.00	0.00	0.00	1.20	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	40.30	7.02	2.70	0.36	0.54	0.36	0.18	0.36	0.36	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	35.14	3.35	1.67	0.00	3.35	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	34.93	3.29	4.52	0.41	0.41	0.00	0.00	0.41	0.00	0.00
Anulus Pulposus Cell, donor1	11248-116E6	11.21	3.09	0.69	0.00	1.14	0.34	0.23	0.34	0.11	0.11
Anulus Pulposus Cell, donor2	11463-119B5	12.74	2.20	0.98	0.24	1.22	0.00	0.73	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	12.13	1.35	0.90	0.00	1.35	0.45	1.35	0.45	0.00	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	21.71	0.87	2.17	0.43	0.43	0.43	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	14.98	0.00	0.00	2.14	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	12.85	1.20	0.60	0.00	0.60	0.00	0.90	0.00	0.00	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	10.12	1.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	3.30	0.00	1.32	0.00	0.66	0.00	0.00	0.00	0.00	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	18.52	0.97	0.65	0.97	0.00	0.00	0.32	0.00	0.00	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	15.53	1.46	0.49	0.49	0.00	0.49	0.97	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	14.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	13.94	1.51	1.51	0.38	0.00	0.00	0.00	0.00	0.00	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	11.61	0.73	0.00	0.00	1.45	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	13.79	0.00	0.00	0.00	0.00	0.00	1.25	1.25	1.25	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	12.68	1.98	0.49	0.33	0.82	0.16	0.16	0.49	0.00	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	17.74	1.36	1.36	0.00	0.00	0.00	2.73	1.36	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	8.75	0.60	0.45	0.00	0.45	0.15	0.00	0.15	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	12.86	0.54	0.54	0.00	0.54	0.54	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	12.28	1.13	0.38	0.38	0.38	0.00	0.00	0.38	0.00	0.19
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	13.90	1.87	0.27	0.00	0.27	0.27	0.00	0.00	0.00	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	11.71	0.98	2.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	13.77	0.83	1.66	0.00	0.66	0.66	0.00	0.33	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	4.80	0.00	0.00	0.00	1.20	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	10.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	14.41	1.37	2.74	0.51	0.51	0.00	0.51	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	12.58	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	12.14	0.00	0.49	0.00	0.97	0.97	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	11.38	0.76	0.00	0.76	0.38	0.00	0.00	0.38	0.00	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	18.17	1.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	8.55	1.14	1.14	0.57	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	12.83	1.71	1.28	0.64	0.86	0.00	0.21	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	10.58	1.29	0.00	0.26	1.03	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	13.14	0.47	0.94	0.47	0.47	0.94	1.41	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	16.40	2.25	1.29	0.96	0.00	0.32	0.32	0.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	9.27	0.00	0.71	0.00	0.71	0.71	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	12.28	0.58	0.58	0.00	1.17	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	12.34	0.60	0.90	0.30	1.20	0.30	0.00	0.00	0.30	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	3.56	0.00	0.00	0.00	2.38	0.00	1.19	1.19	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	17.29	0.51	1.02	0.51	0.51	1.02	0.51	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	15.79	0.51	0.76	0.25	1.53	0.00	0.51	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	14.61	1.27	1.91	0.00	0.64	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	14.67	0.86	0.86	0.43	1.29	0.43	1.29	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	11.01	1.91	1.27	0.42	0.85	0.21	0.21	0.21	0.21	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	8.70	0.87	0.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	11.34	0.94	0.94	0.00	0.00	0.00	0.94	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	13.90	1.70	1.02	0.17	0.85	0.34	0.34	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	9.27	0.00	0.00	0.00	2.32	0.00	0.00	0.00	0.00	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	23.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	16.51	0.86	2.14	0.43	0.86	0.00	0.21	0.21	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	12.03	1.20	0.00	0.00	0.60	0.00	0.60	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	11.66	0.00	0.00	0.00	0.73	0.00	0.73	0.00	0.00	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	14.25	0.92	0.00	0.00	0.46	0.46	0.23	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	12.75	2.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	9.41	0.51	1.02	0.00	0.25	0.51	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	14.24	0.41	2.06	0.62	0.41	0.41	0.83	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	14.08	0.00	0.61	0.31	0.31	0.31	0.31	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	16.73	1.43	0.96	0.00	0.00	0.48	0.00	0.48	0.00	0.48
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	13.08	1.33	0.89	0.00	1.33	0.44	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	15.26	0.00	0.00	1.53	0.00	1.53	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	11.08	2.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.11
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	12.71	0.79	1.06	0.53	0.26	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	12.72	0.36	1.09	0.00	0.36	0.00	0.36	0.00	0.00	0.00
Astrocyte - cerebellum, donor1	11500-119F6	87.57	8.72	4.91	0.74	2.33	2.09	0.25	0.49	0.00	0.12
Astrocyte - cerebellum, donor2	11580-120F5	67.61	6.50	3.94	0.86	1.88	1.20	0.51	0.51	0.00	0.00
Astrocyte - cerebellum, donor3	11661-122F5	48.03	3.57	1.47	0.00	1.68	0.42	0.63	0.21	0.00	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	43.92	3.83	3.49	0.70	0.70	0.70	0.35	0.35	0.00	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	69.08	3.88	4.21	0.32	2.91	1.13	0.81	0.32	0.00	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	67.57	5.37	5.37	1.34	2.09	0.30	0.60	0.15	0.30	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	92.90	8.95	9.17	1.26	0.57	1.03	1.15	1.38	0.23	0.11
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	110.62	8.27	10.02	1.25	0.25	1.13	1.88	1.00	0.25	0.38
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	99.69	6.49	8.53	1.14	0.80	1.02	2.16	0.80	0.23	0.11
Basophils, donor1	12241-129G9	7.85	7.85	0.78	1.31	0.00	0.00	0.00	0.00	0.00	0.00
Basophils, donor2	12242-129H1	12.63	7.22	1.44	0.36	0.00	0.00	0.00	0.00	0.00	0.00
Basophils, donor3	12243-129H2	12.64	8.82	1.76	0.88	0.15	0.00	0.00	0.15	0.00	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	37.73	6.04	2.59	1.08	0.22	0.00	0.43	0.00	0.22	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	28.80	0.91	2.29	1.83	0.00	0.00	0.46	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	43.04	7.17	14.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	24.48	1.26	1.88	0.00	0.00	0.00	0.00	1.26	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	50.53	1.66	5.41	1.66	0.21	0.00	1.25	0.42	0.21	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	25.79	2.07	3.68	0.23	0.46	0.00	0.46	0.69	0.23	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	21.05	4.86	5.40	0.54	0.36	0.00	0.18	0.00	0.00	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	155.41	6.39	8.55	1.44	6.90	6.80	0.93	0.72	0.31	0.31
Burkitt's lymphoma cell line:RAJI	10476-106I8	150.92	4.66	8.15	1.16	2.79	0.70	0.93	0.70	0.93	0.00
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	29.42	7.67	2.24	0.96	4.16	0.64	0.00	0.00	0.32	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	10.34	0.00	0.00	0.00	10.34	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	12.96	9.58	0.56	0.56	0.00	0.00	0.00	0.00	1.13	0.00
CD14+ Monocytes, donor2	11305-117B9	13.18	7.42	1.11	0.93	0.19	0.19	0.56	0.00	0.00	0.00
CD14+ Monocytes, donor3	11381-118B4	10.76	8.34	1.54	0.22	0.22	0.00	0.22	0.22	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	8.49	10.76	1.13	0.57	0.57	0.28	0.00	0.28	0.28	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	9.10	10.24	1.52	0.76	0.76	0.00	0.38	0.00	0.38	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	13.81	10.19	1.31	0.33	1.64	0.00	0.00	0.99	0.66	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	7.52	5.78	0.58	0.29	0.14	0.14	0.58	0.29	0.29	0.00
CD14+ monocytes - mock treated, donor2	11873-125C1	6.03	3.92	0.91	0.00	0.00	0.00	0.00	0.30	0.00	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	10.42	4.74	0.47	0.95	0.00	0.24	0.24	0.00	0.47	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	5.02	3.68	0.17	0.00	0.00	0.00	0.33	0.33	0.00	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	7.73	2.48	0.55	0.28	0.00	0.00	0.28	0.00	0.28	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	6.20	3.47	0.74	0.74	0.00	0.00	0.99	0.25	0.00	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	3.92	2.35	0.20	0.39	0.00	0.00	0.00	0.20	0.00	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	7.48	2.67	0.18	0.36	0.00	0.00	0.18	0.00	0.00	0.18
CD14+ monocytes - treated with BCG, donor3	11880-125C8	3.48	1.96	0.44	0.00	0.00	0.00	0.00	0.00	0.00	0.44
CD14+ monocytes - treated with Candida, donor1	11868-125B5	3.04	3.28	0.00	0.00	0.00	0.00	0.23	0.00	0.00	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	10.03	1.58	0.00	0.00	0.00	0.00	1.58	0.00	0.00	1.58
CD14+ monocytes - treated with Candida, donor3	11888-125D7	11.09	2.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	5.80	4.91	0.89	0.00	0.00	0.00	0.30	0.45	0.45	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	8.38	3.79	0.40	0.40	0.00	0.00	0.40	0.00	0.00	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	3.33	3.96	0.21	0.21	0.00	0.00	0.21	0.21	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	5.26	4.12	0.23	0.23	0.00	0.00	0.23	0.69	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	7.24	2.71	0.68	0.00	0.00	0.00	0.00	0.23	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	5.24	2.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.44
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	5.38	2.42	0.27	0.27	0.00	0.00	0.27	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	8.20	4.19	0.87	0.35	0.00	0.00	0.35	0.00	0.35	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	6.31	2.95	1.68	0.00	0.00	0.00	0.00	0.00	0.00	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	2.76	2.76	0.18	0.00	0.00	0.00	0.00	0.00	0.00	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	3.87	3.17	0.00	0.70	0.00	0.00	0.35	0.00	0.00	1.06
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	5.70	3.07	0.00	0.00	0.00	0.00	0.00	0.00	0.44	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	4.88	3.84	0.52	0.17	0.00	0.00	0.17	0.35	0.17	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	5.95	1.86	1.12	0.37	0.00	0.00	0.00	0.00	0.00	0.74
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	5.82	1.72	0.00	0.00	0.00	0.00	0.00	0.00	0.22	0.65
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	7.37	4.91	0.82	0.00	0.00	0.00	1.23	0.00	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	6.49	3.25	0.23	0.23	0.00	0.00	0.00	0.23	0.00	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	2.78	2.32	0.46	0.46	0.00	0.00	0.23	0.00	0.00	0.46
CD14+CD16+ Monocytes, donor1	11789-124B7	4.58	4.14	0.22	0.87	0.22	0.00	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	8.32	3.70	0.69	0.46	0.23	0.00	0.00	0.00	0.00	0.23
CD14+CD16+ Monocytes, donor3	11912-125G4	4.55	4.77	0.43	0.22	0.00	0.00	0.22	0.00	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	14.33	8.10	0.78	0.62	0.16	0.00	0.16	0.16	0.16	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	8.91	6.64	0.87	0.35	0.00	0.00	0.17	0.00	0.00	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	13.82	13.82	1.56	0.45	0.45	0.00	0.00	0.22	0.22	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	4.85	5.61	0.77	0.26	0.51	0.00	0.00	0.00	0.26	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	3.51	4.39	0.66	0.66	0.00	0.00	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	4.42	4.84	1.05	1.05	0.21	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	6.10	8.13	0.00	0.00	2.03	0.00	0.00	4.06	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	6.10	5.42	0.68	2.03	0.68	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	7.25	4.14	1.04	1.04	1.04	0.00	0.00	0.00	0.00	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	6.93	8.53	1.60	0.00	0.53	0.00	0.00	0.00	0.53	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	12.33	4.82	1.61	0.00	2.14	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	10.53	7.02	0.00	0.00	0.00	0.00	0.70	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	7.06	5.49	0.78	1.57	0.78	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	10.55	6.59	1.32	1.32	1.32	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	13.97	9.86	0.82	2.47	1.64	0.82	0.00	0.82	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	13.06	6.53	0.73	0.00	0.00	0.00	0.00	0.73	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	19.18	6.06	1.01	0.50	1.51	0.00	1.51	1.01	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	9.70	14.55	0.00	2.02	0.00	0.00	0.81	0.40	0.00	0.81
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	9.99	13.18	1.60	0.00	0.00	0.00	0.00	0.40	0.00	0.40
CD34+ Progenitors, donor1	11545-120B6	27.11	3.01	0.00	0.00	2.01	1.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	12.36	2.25	1.12	0.00	1.12	0.56	0.00	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	37.95	6.39	8.27	1.13	2.63	0.38	0.00	0.00	0.00	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	36.75	4.74	2.93	0.90	1.80	0.23	0.23	0.00	0.23	0.23
CD4+ T Cells, donor1	11225-116C1	31.06	13.93	5.71	1.79	1.07	0.00	0.71	1.43	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	26.94	8.57	2.45	0.00	0.00	0.61	1.84	0.61	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	18.30	10.06	3.35	1.83	0.61	0.00	0.30	0.30	0.30	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	16.59	9.44	2.55	0.77	1.02	0.26	0.51	0.26	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	23.36	5.39	2.47	0.67	0.67	0.00	0.67	0.67	0.00	0.45
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	19.55	6.61	1.15	0.86	0.29	0.57	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	14.70	9.01	2.37	0.95	0.00	0.00	0.47	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	14.05	5.62	2.11	0.70	0.00	0.00	1.40	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	19.78	16.48	3.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	12.57	3.76	1.45	1.01	0.14	0.29	0.29	0.29	0.14	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	18.98	5.25	3.56	1.36	0.68	0.17	0.51	0.17	0.00	0.51
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	15.96	5.48	2.74	0.97	0.32	0.00	0.00	0.48	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	11.66	5.83	1.34	0.00	0.45	0.00	0.90	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	10.48	3.84	1.40	0.70	0.35	0.00	0.35	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	12.76	7.48	0.88	1.76	0.00	0.00	0.88	0.44	0.88	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	16.02	6.32	0.84	0.00	0.00	0.00	0.00	0.42	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	19.74	6.03	3.12	1.25	1.04	0.21	0.42	0.21	0.00	0.21
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	14.70	3.01	0.33	0.00	0.00	0.00	0.00	0.00	0.00	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	22.57	9.79	2.45	0.82	0.82	0.00	0.54	0.54	0.00	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	25.73	16.08	0.54	1.07	1.61	0.54	0.00	1.07	0.54	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	7.17	7.17	3.59	1.79	0.00	0.00	1.79	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	21.32	9.46	1.67	0.74	0.56	0.19	0.74	0.19	0.19	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	21.66	6.93	2.17	0.43	0.22	0.43	0.22	0.22	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	15.97	7.36	1.26	1.26	0.21	0.00	0.42	0.21	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	9.61	7.58	2.02	0.00	0.00	0.00	0.00	0.51	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	12.56	3.47	1.73	0.00	0.00	0.00	0.87	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	13.95	9.15	1.74	1.74	0.87	0.00	0.87	0.44	0.44	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	18.31	7.92	4.45	1.98	0.99	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	17.54	12.00	1.85	0.00	1.85	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	15.35	9.77	1.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	19.66	13.02	1.94	3.32	0.83	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	18.40	13.74	2.45	2.45	0.98	0.00	0.00	0.74	0.25	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	20.02	9.24	1.54	0.00	0.00	0.00	1.54	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	21.13	10.39	1.79	1.43	1.43	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	18.00	9.69	0.00	1.38	1.38	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	25.54	14.08	1.31	0.00	0.00	0.00	0.65	0.33	0.00	0.65
CD8+ T Cells, donor2	11307-117C2	15.39	11.64	1.88	1.88	0.00	0.00	1.50	0.00	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	25.25	16.66	3.79	1.26	1.26	0.00	1.51	0.76	0.00	0.50
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	30.05	2.29	2.06	0.23	0.46	0.00	0.46	0.23	0.00	0.46
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	30.43	0.72	1.20	0.24	0.24	0.48	0.00	0.24	0.24	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	29.27	1.37	0.82	0.27	0.27	0.00	0.27	0.27	0.55	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	33.92	1.50	2.40	0.60	0.30	0.30	0.00	0.30	0.00	0.30
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	33.12	1.92	1.92	0.96	0.96	0.24	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	32.97	2.05	0.45	0.68	0.68	0.23	0.23	0.45	0.00	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	32.59	1.09	2.39	0.65	0.22	0.00	0.00	0.43	0.22	0.00
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	35.80	1.84	3.16	0.26	0.00	0.00	0.26	0.26	0.00	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	32.13	2.35	2.35	0.47	0.00	0.00	0.23	0.47	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	37.73	2.72	2.11	0.60	0.00	0.30	0.30	0.00	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	35.15	0.87	2.91	1.16	0.58	0.00	0.00	0.29	0.29	0.58
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	35.44	1.87	2.40	0.00	1.33	0.27	0.53	0.27	0.00	0.27
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	28.89	2.63	3.50	0.88	0.44	0.00	0.00	0.44	0.00	2.19
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	28.69	2.28	1.82	0.46	0.00	0.00	0.00	0.46	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	32.07	1.49	2.24	0.00	0.00	0.00	0.00	0.75	0.00	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	33.85	1.80	2.16	0.36	0.00	0.00	0.36	0.36	0.36	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	39.42	2.59	2.30	0.58	0.29	0.00	0.00	0.29	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	35.83	2.83	1.65	0.24	0.00	0.00	0.00	0.94	0.24	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	39.93	3.49	1.90	0.63	0.00	0.00	0.63	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	37.83	2.77	3.38	0.92	0.31	0.00	0.62	0.31	0.00	0.31
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	38.79	1.60	3.85	0.64	0.96	0.64	0.00	0.96	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	33.27	1.15	1.15	0.00	0.00	0.00	0.00	0.38	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	26.41	0.39	0.00	0.39	0.00	0.39	0.00	0.39	0.39	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	33.28	3.03	0.76	0.00	0.00	0.00	0.00	0.00	0.76	1.51
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	32.12	2.41	2.41	0.00	0.00	0.80	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	34.97	3.50	4.20	0.00	1.40	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	50.09	4.01	3.01	1.00	2.00	1.00	0.00	1.00	0.00	1.00
Cardiac Myocyte, donor1	11525-119I4	21.93	5.48	0.00	0.00	0.00	0.00	1.83	0.00	1.83	0.00
Cardiac Myocyte, donor2	11605-120I3	20.75	1.98	1.98	0.00	0.00	0.99	0.99	0.00	0.00	0.00
Cardiac Myocyte, donor3	11686-122I3	19.68	1.05	2.32	0.21	0.63	0.42	0.11	0.11	0.00	0.11
Chondrocyte - de diff, donor1	11261-116G1	11.44	2.43	0.69	1.04	1.04	0.00	0.35	0.00	0.00	0.00
Chondrocyte - de diff, donor2	11338-117F6	7.46	1.78	0.71	0.00	1.78	0.00	0.00	0.00	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	11.72	2.50	1.14	0.57	0.23	0.46	0.11	0.11	0.00	0.00
Chondrocyte - re diff, donor2	11339-117F7	16.11	1.79	0.90	0.90	0.90	0.00	0.00	0.00	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	15.37	4.04	0.40	0.40	0.81	0.00	0.40	0.00	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	51.30	4.93	2.07	0.57	2.07	0.69	0.80	0.34	0.00	0.11
Ciliary Epithelial Cells, donor2	11323-117D9	43.82	3.63	2.78	0.21	0.64	0.21	0.64	0.86	0.00	0.43
Ciliary Epithelial Cells, donor3	11399-118D4	54.43	4.51	3.19	0.97	1.59	0.62	1.50	0.44	0.09	0.18
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	38.51	14.40	10.27	2.84	2.57	0.64	0.55	0.92	0.18	0.28
Corneal Epithelial Cells, donor1	11526-119I5	39.08	5.05	4.39	0.44	0.66	0.00	0.00	0.44	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	27.30	2.28	0.00	2.28	0.00	0.00	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	31.44	4.35	3.83	1.28	0.26	0.00	1.02	0.77	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	22.12	2.64	1.49	0.17	0.99	0.17	0.00	0.33	0.00	0.00
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	21.13	2.52	0.32	0.32	0.95	0.00	0.00	0.00	0.32	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	13.80	3.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	17.71	2.27	1.08	0.22	0.65	0.22	0.32	0.22	0.22	0.11
Dendritic Cells - plasmacytoid, donor1	11228-116C4	15.03	3.76	1.02	0.00	0.68	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	10.45	1.96	1.31	0.00	0.00	1.96	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	13.07	5.81	1.94	0.00	0.97	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	46.03	3.34	6.17	1.17	1.33	0.17	0.17	0.33	0.17	0.33
Endothelial Cells - Aortic, donor1	11263-116G3	28.17	1.76	1.76	0.00	0.59	0.00	0.59	0.59	0.00	1.17
Endothelial Cells - Aortic, donor2	11340-117F8	54.86	5.09	1.98	1.70	1.70	0.00	0.28	1.13	0.28	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	46.00	4.72	2.36	0.79	0.00	0.00	0.79	0.00	0.00	0.39
Endothelial Cells - Artery, donor1	11264-116G4	35.78	2.33	3.78	1.16	1.16	0.29	0.29	0.29	0.00	0.00
Endothelial Cells - Artery, donor2	11341-117F9	51.06	3.76	4.47	0.94	1.18	0.24	0.94	0.00	0.47	0.24
Endothelial Cells - Artery, donor3	11413-118E9	46.98	3.68	2.98	0.88	0.53	0.53	0.18	0.00	0.35	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	30.37	3.10	3.10	1.33	0.66	0.00	0.22	0.44	0.00	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	27.69	3.65	4.56	0.91	0.91	0.00	0.00	0.30	0.30	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	33.55	1.41	1.41	0.85	1.41	0.00	0.00	0.56	0.00	0.56
Endothelial Cells - Microvascular, donor1	11265-116G5	29.42	1.49	2.67	0.89	1.49	0.00	0.00	0.30	0.00	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	27.60	0.52	1.04	0.00	0.52	0.00	0.00	0.00	0.52	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	26.51	1.99	1.99	0.28	0.57	0.43	0.14	0.43	0.43	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	51.62	3.20	2.80	0.80	0.40	0.40	0.40	0.80	0.40	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	40.88	1.57	2.10	0.52	0.52	0.00	0.52	0.52	0.00	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	50.82	6.83	3.73	0.75	1.37	0.62	0.50	1.37	0.37	0.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	48.67	7.60	3.91	2.39	1.09	0.87	0.22	0.00	0.43	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	55.32	7.57	7.57	1.10	1.95	0.24	0.49	0.00	0.00	0.24
Endothelial Cells - Vein, donor1	11267-116G7	58.01	2.28	4.55	0.00	1.14	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	63.56	1.40	2.79	0.70	1.40	1.40	0.00	1.40	0.70	0.00
Endothelial Cells - Vein, donor3	11416-118F3	64.69	2.67	5.34	0.79	1.73	0.79	0.63	0.47	0.16	0.31
Eosinophils, donor1	12244-129H3	0.00	15.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	4.95	8.25	0.00	1.65	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	7.13	14.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	33.96	5.62	2.44	0.73	0.24	0.00	0.24	0.24	0.24	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	12.48	2.08	0.00	2.08	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	16.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	15.60	2.87	0.82	0.41	0.00	0.00	0.82	0.00	0.41	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	6.02	0.66	0.44	0.33	0.66	0.11	0.11	0.11	0.00	0.11
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	13.87	1.30	1.52	0.33	0.87	0.11	0.33	0.22	0.11	0.11
Fibroblast - Aortic Adventitial, donor1	11245-116E3	28.26	1.82	1.21	0.49	0.36	0.12	0.61	0.73	0.36	0.00
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	32.34	3.96	3.28	0.82	0.41	0.55	0.27	0.14	0.14	0.00
Fibroblast - Aortic Adventitial, donor2	11326-117E3	21.94	1.90	1.27	0.42	0.63	0.11	0.74	0.74	0.00	0.11
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	39.52	3.95	2.11	0.26	0.79	1.32	0.26	1.05	0.53	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	29.90	1.66	3.65	1.66	0.33	0.33	0.00	1.00	0.00	0.00
Fibroblast - Cardiac, donor1	11268-116G8	33.57	1.36	2.27	0.45	0.00	0.45	0.00	0.00	0.00	0.00
Fibroblast - Cardiac, donor2	11345-117G4	40.93	1.52	1.52	0.00	0.76	0.00	0.76	1.52	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	22.87	1.89	2.37	0.47	0.95	0.00	0.32	0.00	0.47	0.00
Fibroblast - Cardiac, donor4	11452-119A3	28.49	6.06	5.46	0.61	2.73	0.91	0.00	0.00	0.30	0.00
Fibroblast - Cardiac, donor5	11456-119A7	24.62	2.54	2.79	0.63	0.89	0.51	0.76	0.51	0.00	0.13
Fibroblast - Cardiac, donor6	11460-119B2	31.38	2.88	1.97	0.15	1.21	0.15	0.45	0.15	0.15	0.15
Fibroblast - Choroid Plexus, donor1	11492-119E7	42.74	3.35	2.55	0.80	1.61	0.27	0.40	0.54	0.13	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	22.87	2.16	1.29	0.43	0.43	0.00	0.43	0.00	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	58.59	1.46	2.93	1.46	1.46	0.00	0.00	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	48.90	7.84	4.15	0.69	3.23	1.85	0.00	1.15	0.69	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	11.53	0.85	0.68	0.17	1.87	1.02	0.00	0.00	0.00	0.17
Fibroblast - Dermal, donor1	11269-116G9	19.02	3.05	2.82	0.70	0.70	0.00	0.47	0.00	0.47	0.00
Fibroblast - Dermal, donor2	11346-117G5	31.60	2.36	3.30	0.47	0.94	0.00	0.47	0.00	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	18.74	2.06	2.06	0.24	0.12	0.12	0.73	0.24	0.36	0.00
Fibroblast - Dermal, donor4	11450-119A1	40.92	3.73	2.94	0.90	0.57	0.23	0.23	0.45	0.23	0.11
Fibroblast - Dermal, donor5	11454-119A5	41.17	2.44	2.97	0.52	1.40	0.70	0.70	0.35	0.35	0.00
Fibroblast - Dermal, donor6	11458-119A9	47.59	2.11	4.87	0.65	0.81	1.14	0.32	0.65	0.00	0.00
Fibroblast - Gingival, donor1	11237-116D4	20.82	3.12	2.50	0.42	0.83	0.00	0.00	0.21	0.00	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	28.30	5.24	3.41	0.00	2.10	0.52	0.00	0.00	0.79	0.00
Fibroblast - Gingival, donor2	11318-117D4	36.11	3.82	2.90	0.92	0.79	0.53	0.66	0.40	0.13	0.13
Fibroblast - Gingival, donor3	11394-118C8	16.15	3.58	1.93	0.29	1.64	0.19	0.00	0.29	0.10	0.10
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	14.54	0.00	3.12	0.00	1.04	0.00	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	13.74	2.29	1.59	0.35	0.70	0.18	0.88	0.35	0.00	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	27.13	4.83	2.81	1.25	0.78	0.31	0.62	0.47	0.16	0.16
Fibroblast - Gingival, donor6 (control)	11922-125H5	25.29	2.43	2.03	0.81	0.81	0.41	0.27	0.54	0.27	0.00
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	56.11	7.06	6.70	1.76	1.06	0.00	0.00	1.06	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	29.10	3.95	2.19	0.44	0.88	0.73	0.15	0.15	0.15	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	22.91	2.59	1.64	0.41	1.09	0.27	0.14	0.00	0.00	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	35.21	3.07	3.51	0.55	0.33	0.33	0.11	0.11	0.33	0.00
Fibroblast - Gingival, donor9 (control)	11927-125I1	20.10	2.20	1.61	0.44	2.20	1.17	0.15	0.59	0.44	0.00
Fibroblast - Lung, donor1	11270-116H1	29.91	2.72	4.08	1.36	0.00	1.36	0.00	2.72	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	28.35	7.46	1.49	0.00	2.98	1.49	1.49	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	36.72	4.01	2.74	1.27	1.48	0.21	0.21	0.21	0.21	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	58.31	10.00	4.17	0.83	0.83	0.00	0.00	1.67	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	32.17	1.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	15.67	0.84	1.40	0.28	0.28	0.28	0.28	0.00	0.00	0.00
Fibroblast - Mammary, donor1	11540-120B1	54.81	4.87	4.06	1.22	0.81	0.00	0.00	0.81	0.00	0.41
Fibroblast - Mammary, donor2	11620-122A9	31.95	0.00	0.00	0.00	0.00	0.00	3.99	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	29.78	5.96	0.00	0.00	5.96	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	39.96	2.33	1.75	0.19	1.75	0.58	0.39	0.19	0.00	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	58.40	6.07	5.01	1.06	2.12	1.37	2.43	0.61	0.15	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	31.52	3.98	2.75	0.31	0.61	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	23.66	3.05	3.05	0.00	0.38	0.76	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	15.93	2.43	1.62	0.54	0.81	0.00	0.81	0.00	0.27	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	15.54	3.60	2.44	0.70	1.16	0.12	0.23	0.00	0.00	0.00
Fibroblast - Pulmonary Artery, donor1	11250-116E8	19.90	2.43	2.43	0.22	0.66	0.00	0.00	0.22	0.00	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	52.22	4.67	4.47	1.22	1.22	0.20	0.00	0.81	0.20	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	23.39	2.00	2.00	0.67	0.67	1.34	0.67	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	14.63	1.19	0.79	0.40	1.98	0.40	0.40	0.40	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	73.03	9.92	6.15	0.79	0.79	0.60	0.79	1.19	0.79	0.60
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	9.59	1.78	1.07	0.53	0.71	0.18	0.18	0.18	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	15.57	2.17	1.38	0.59	0.39	0.39	0.20	0.20	0.39	0.00
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	55.96	3.31	3.91	0.60	0.60	0.30	0.30	0.00	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	24.29	1.62	2.27	0.86	1.30	0.11	0.11	0.11	0.22	0.32
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	33.66	4.56	3.80	1.01	0.76	0.00	0.51	0.00	0.00	0.00
Fibroblast - skin normal, donor1	11553-120C5	12.63	3.12	1.80	0.16	0.98	0.16	0.00	0.16	0.33	0.00
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	61.15	6.22	7.42	1.40	0.80	0.20	0.60	1.00	0.00	0.00
Fibroblast - skin normal, donor2	11561-120D4	19.99	2.61	1.71	0.60	0.80	0.40	0.50	0.20	0.30	0.10
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	63.47	8.76	6.65	3.02	0.91	0.91	0.91	0.30	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	16.07	2.65	1.82	0.08	0.66	0.17	0.17	0.17	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	14.70	2.56	1.54	0.34	1.88	0.68	0.34	0.85	0.00	0.68
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	45.32	4.93	4.60	1.64	1.64	0.99	0.33	0.00	0.00	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	24.71	3.20	2.02	1.49	0.75	0.32	0.21	0.64	0.11	0.00
Fibroblast - skin walker warburg, donor1	11554-120C6	31.21	2.70	2.19	0.51	0.17	0.17	0.51	0.17	0.17	0.17
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	4.70	1.41	1.10	0.31	0.16	0.31	0.31	0.16	0.00	0.00
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	0.00	0.00	0.00	0.00	0.00	0.00	44.32	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	24.40	2.61	2.61	0.00	0.00	0.00	1.74	0.87	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	19.42	1.39	1.73	0.69	0.17	0.00	0.17	0.17	0.17	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	24.98	2.08	3.12	1.56	0.78	0.26	0.00	0.52	0.00	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	27.85	3.07	2.81	1.53	1.53	0.00	0.00	0.51	0.26	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	64.31	6.89	0.77	0.00	1.53	0.77	1.53	2.30	5.36	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	61.89	3.83	2.55	0.64	1.91	0.64	0.64	2.55	1.91	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	88.15	5.71	7.42	0.86	0.29	1.71	1.71	1.71	1.14	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	127.68	6.89	8.82	2.21	6.34	1.93	2.21	4.96	10.20	0.55
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	106.86	5.25	5.71	1.14	4.11	1.60	1.14	6.16	4.34	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	99.07	7.53	7.33	1.19	1.59	1.19	2.58	1.98	2.77	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	131.11	5.55	8.99	1.85	2.91	1.32	1.85	5.29	7.93	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	112.52	4.24	5.87	1.30	3.26	1.63	0.98	4.57	3.26	0.33
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	72.52	3.98	4.42	1.33	0.88	0.88	1.77	3.10	1.33	0.88
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	79.28	7.35	7.77	1.70	2.26	2.97	0.99	0.71	0.14	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	78.56	9.61	7.88	1.23	3.94	1.23	2.22	0.74	0.25	0.49
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	63.66	8.06	7.25	0.54	0.81	1.34	1.61	0.54	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	81.65	4.34	5.82	0.50	4.21	0.62	0.62	0.87	1.12	0.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	68.11	4.29	5.26	1.25	1.66	0.55	0.97	0.83	0.42	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	48.39	2.64	3.25	1.22	1.42	0.41	1.42	0.61	0.20	0.61
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	67.54	4.79	5.70	0.68	2.97	1.37	0.68	0.23	0.46	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	61.41	6.23	5.11	0.75	1.87	0.25	1.12	0.87	0.50	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	65.35	7.87	4.15	1.31	1.53	0.66	1.09	0.44	0.44	0.22
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	56.14	3.84	2.66	0.30	3.25	2.07	1.77	0.30	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	82.82	5.56	5.72	0.79	3.66	1.59	1.43	0.48	0.32	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	64.57	6.93	2.90	1.12	3.35	0.67	0.67	0.00	0.89	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	72.18	2.82	1.61	1.01	3.02	1.21	0.60	0.81	0.40	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	82.79	7.46	3.39	1.19	3.39	1.53	1.70	0.68	0.34	0.51
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	77.50	6.38	3.37	0.44	1.95	1.15	0.44	0.71	0.98	0.35
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	117.69	3.43	4.16	0.73	3.75	1.87	0.62	1.25	0.83	0.10
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	90.85	3.93	2.73	0.51	5.29	1.37	0.00	1.88	0.85	0.34
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	81.77	5.42	4.87	0.89	2.88	1.77	1.11	0.66	1.11	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	66.06	5.07	3.08	0.42	1.66	1.58	0.17	0.33	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	64.93	6.13	3.47	0.41	2.65	1.02	0.00	0.20	0.82	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	64.16	4.75	3.51	0.62	3.30	1.24	0.83	0.83	1.03	0.21
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	85.32	4.61	4.38	1.15	3.23	1.38	1.73	1.04	0.58	0.23
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	59.87	5.00	3.67	0.17	1.50	1.67	0.67	0.00	0.33	0.33
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	60.18	3.09	3.31	0.88	2.42	1.32	0.22	1.10	0.88	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	68.26	6.76	4.06	0.61	3.44	1.72	1.48	0.86	0.61	0.12
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	77.97	4.05	3.73	1.13	3.73	2.27	0.16	0.81	0.32	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	59.33	6.09	3.85	0.32	2.57	2.25	0.96	0.32	0.00	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	66.52	3.98	3.22	0.19	2.18	1.04	1.14	0.47	0.47	0.19
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	56.94	3.64	3.01	1.11	1.74	0.63	0.00	0.16	1.11	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	65.38	3.95	2.13	0.00	6.39	1.22	1.52	1.82	0.30	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	64.71	3.87	3.87	0.84	1.25	0.73	0.52	0.31	0.52	0.42
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	44.13	3.73	3.07	0.66	1.10	1.32	0.44	1.32	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	53.30	5.33	3.93	1.12	3.37	1.12	0.84	0.28	1.12	0.56
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	65.55	3.80	3.15	1.20	2.04	0.83	0.65	1.20	0.37	0.19
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	38.77	2.67	1.34	0.27	0.80	0.00	0.80	0.53	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	56.76	2.75	3.21	0.61	1.22	0.00	1.07	0.31	0.46	0.15
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	46.63	2.59	3.63	0.52	1.81	0.52	0.91	0.39	0.39	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	38.22	5.15	2.71	0.27	3.80	0.54	0.27	0.27	0.54	0.27
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	47.75	4.98	1.66	0.55	1.11	0.74	0.92	0.37	0.18	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	47.81	5.92	2.41	0.22	1.97	0.22	0.66	1.32	0.44	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	58.51	7.93	3.97	0.00	6.94	1.98	0.00	0.99	0.99	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	43.00	3.30	2.77	0.53	2.24	0.79	0.79	0.26	0.26	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	32.89	2.82	1.01	0.20	1.82	0.00	0.61	0.40	0.00	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	61.51	7.12	2.54	0.51	7.62	1.02	0.00	1.02	0.51	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	80.82	4.78	6.57	1.79	0.80	3.78	1.19	0.60	1.00	0.40
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	82.89	8.47	9.09	2.47	1.08	1.69	1.23	0.92	0.15	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	104.34	7.36	8.18	1.64	3.07	2.86	2.45	0.82	1.02	0.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	72.91	2.50	3.44	0.31	1.88	0.31	0.63	0.31	0.63	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	53.40	2.54	2.54	0.00	1.13	0.85	0.57	0.57	0.57	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	78.40	4.61	7.84	0.46	1.38	2.77	3.23	0.92	0.00	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	94.04	4.95	2.47	0.00	2.47	0.00	0.00	2.47	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	89.74	2.71	2.71	0.39	0.39	1.55	1.55	0.00	2.32	0.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	62.57	0.00	8.02	0.00	1.60	0.00	1.60	0.00	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	88.68	1.74	5.22	0.00	3.48	1.74	1.74	0.00	1.74	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	67.05	3.25	4.23	0.33	1.63	2.28	2.28	0.33	0.98	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	74.54	4.94	3.29	0.00	1.65	1.24	2.47	0.41	0.41	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	103.30	0.00	3.33	0.00	3.33	0.00	6.66	6.66	3.33	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	79.42	2.24	5.59	0.28	1.68	0.56	1.40	0.28	0.56	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	81.06	2.61	3.60	0.65	2.29	0.33	2.29	1.31	1.31	0.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	81.37	2.52	5.87	0.84	5.03	0.00	3.36	0.84	1.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	85.88	4.45	3.82	0.32	2.86	1.59	0.64	0.32	0.32	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	67.25	2.72	3.06	0.34	1.36	1.36	1.02	0.34	0.00	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	56.38	0.00	4.18	0.00	0.00	2.09	0.00	2.09	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	71.01	5.15	4.01	2.29	5.73	0.57	1.72	0.57	1.15	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	63.04	2.96	3.55	0.89	3.55	1.48	2.07	0.89	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	69.46	5.08	3.39	1.69	3.39	0.00	3.39	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	78.29	3.73	4.56	0.83	1.66	2.49	2.07	0.83	0.41	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	78.47	4.60	4.37	0.46	2.76	1.38	2.53	0.00	0.46	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	52.68	0.00	5.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	60.74	4.23	8.46	0.00	2.69	1.15	2.31	0.77	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	41.72	1.96	3.59	0.33	0.98	0.65	0.98	0.33	0.98	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	27.42	2.01	5.35	0.00	2.01	0.00	0.67	0.00	0.67	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	58.56	2.31	5.39	0.77	5.78	1.93	2.70	0.77	0.39	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	68.47	6.16	2.40	0.68	2.74	1.37	0.68	0.34	0.34	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	52.18	9.94	4.97	0.00	9.94	0.00	4.97	2.48	2.48	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	54.26	2.36	2.83	0.00	3.77	0.94	1.42	0.00	1.42	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	59.14	7.85	3.02	1.21	3.02	0.00	0.60	0.00	0.00	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	64.09	4.58	5.60	0.00	5.60	3.05	0.51	1.02	0.51	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	65.41	2.79	3.99	0.40	4.39	1.99	1.99	0.40	0.80	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	53.28	2.96	2.47	0.99	0.99	0.99	3.95	0.49	0.00	0.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	53.12	1.18	3.54	1.18	4.72	2.36	4.72	0.00	0.00	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	47.26	3.50	1.17	0.58	3.50	1.75	2.33	0.00	0.00	1.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	56.62	2.63	2.63	0.44	0.00	1.32	1.32	0.44	0.88	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	50.86	1.70	1.70	1.70	2.54	0.00	3.39	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	43.57	2.98	4.18	1.79	1.79	0.60	2.98	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	49.98	2.91	2.91	0.97	0.97	1.46	1.46	0.49	0.00	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	14.84	1.14	4.57	1.14	1.14	1.14	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	12.89	1.66	2.49	0.83	0.00	0.00	0.83	0.00	0.42	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	35.98	3.37	1.12	1.12	0.00	0.00	0.00	2.25	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	9.51	2.85	0.63	0.32	0.32	0.00	0.32	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	4.60	0.42	2.09	0.42	1.67	0.42	0.00	0.00	0.00	0.42
Hep-2 cells mock treated, biol_rep1	11898-125E8	20.08	3.37	4.18	1.28	0.00	0.12	1.16	0.12	0.12	0.00
Hep-2 cells mock treated, biol_rep2	11899-125E9	21.61	4.39	4.05	1.01	0.17	0.51	1.01	0.34	0.34	0.00
Hep-2 cells mock treated, biol_rep3	11900-125F1	21.84	4.10	4.10	1.37	0.23	0.00	0.68	0.23	0.00	0.23
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	20.44	3.83	2.73	0.87	0.22	0.00	0.98	0.22	0.00	0.33
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	23.00	5.37	5.59	1.72	0.00	0.00	0.43	0.21	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	24.54	3.66	2.37	0.43	0.43	0.00	1.29	0.22	0.00	0.00
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	16.81	3.24	2.12	1.12	0.12	0.00	0.37	0.00	0.00	0.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	15.78	3.09	1.72	0.69	0.51	0.00	0.34	0.69	0.00	0.51
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	12.17	3.20	2.88	1.60	0.32	0.32	0.32	0.64	0.32	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	45.89	3.36	6.72	0.56	1.12	2.24	0.56	1.12	0.56	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	54.10	3.03	6.92	0.00	0.43	0.43	1.30	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	31.73	0.00	0.00	2.64	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	41.97	4.59	1.41	1.41	1.06	0.35	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	39.96	3.63	1.45	0.73	0.00	0.00	1.45	0.00	0.73	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	19.58	2.62	0.87	1.05	0.17	0.70	0.87	0.00	0.00	0.70
Hepatocyte, donor1	11523-119I2	6.05	0.00	1.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	8.62	3.23	1.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	17.79	6.14	2.45	0.00	0.00	0.00	0.00	0.00	0.00	0.61
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	122.05	8.48	7.18	0.65	1.96	1.31	3.26	0.65	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	43.17	6.64	4.54	0.17	0.70	0.35	0.70	0.87	0.52	0.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	29.09	2.74	3.02	1.10	0.41	0.14	0.27	0.00	0.00	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	117.80	3.18	9.55	0.00	3.18	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	40.05	6.68	13.35	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	108.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	84.45	1.38	12.46	0.00	0.00	0.00	0.00	2.77	1.38	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	50.05	2.50	5.01	2.50	0.00	0.00	0.00	0.00	2.50	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	59.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	82.01	7.69	5.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	45.71	0.00	22.85	4.57	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	77.97	6.50	11.37	0.00	0.00	0.00	3.25	1.62	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	76.70	1.67	11.67	1.67	1.67	0.00	0.00	1.67	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	18.15	0.00	0.00	0.00	0.00	0.00	3.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	82.06	1.32	10.59	0.00	0.00	0.00	2.65	2.65	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	85.37	2.22	12.20	5.54	2.22	0.00	0.00	0.00	0.00	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	57.62	0.00	10.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	66.77	0.63	5.04	0.63	1.89	0.00	0.63	1.26	0.00	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	64.96	4.64	13.92	1.55	0.00	0.00	0.00	1.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	58.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	91.09	5.17	8.40	0.65	0.65	0.00	0.65	0.00	0.00	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	114.30	0.00	11.27	1.61	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	95.59	11.95	23.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	85.56	4.89	9.78	0.00	0.81	0.00	0.81	0.81	0.81	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	94.88	2.10	7.98	0.84	0.84	0.84	0.42	0.00	0.42	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	57.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	100.46	1.61	10.45	0.00	0.80	0.00	0.80	1.61	0.00	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	71.09	0.92	9.23	0.00	0.00	0.00	0.92	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	60.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	56.64	2.83	9.44	0.00	1.42	0.00	0.00	0.94	0.47	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	58.05	1.81	5.44	0.91	0.00	0.00	1.81	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	103.20	0.00	14.74	0.00	14.74	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	105.46	1.08	12.91	1.08	1.08	0.00	2.15	2.15	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	91.47	6.35	15.25	0.00	1.27	0.00	1.27	0.00	0.00	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	49.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	93.10	4.46	6.38	0.00	0.64	0.00	2.55	0.00	0.64	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	80.20	3.65	12.76	0.00	0.00	0.00	1.82	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	47.41	0.00	0.00	15.80	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	101.40	3.57	10.00	0.71	0.71	0.00	1.43	2.86	0.71	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	109.50	3.32	6.64	0.00	0.00	0.00	0.00	3.32	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	20.85	20.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	67.60	1.54	7.41	1.54	0.31	0.00	2.16	0.00	0.93	0.31
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	152.77	3.51	15.80	3.51	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	100.58	0.00	12.57	3.14	0.00	0.00	0.00	0.00	0.00	3.14
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	114.74	3.48	10.43	1.39	0.00	0.00	0.70	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	73.03	4.43	4.43	2.21	0.00	0.00	0.00	4.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	100.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	74.11	2.62	9.59	1.74	0.00	0.00	4.36	0.00	0.00	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	83.24	0.00	11.25	4.50	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	69.69	10.45	17.42	0.00	0.00	0.00	3.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	70.41	7.47	8.53	0.00	1.07	0.00	1.07	1.07	1.07	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	90.05	4.16	11.08	2.77	0.00	0.00	1.39	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	74.09	0.00	11.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	69.03	0.00	9.20	0.92	0.00	0.00	2.76	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	12.10	0.00	9.08	0.00	0.00	3.03	3.03	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	55.88	6.21	12.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	42.29	7.40	5.29	1.06	1.06	0.00	2.11	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	36.88	1.47	1.71	0.82	0.41	0.00	0.41	0.57	0.16	0.00
Keratinocyte - epidermal, donor2	11349-117G8	15.81	3.51	0.59	0.59	0.00	0.59	0.00	0.00	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	26.79	3.79	3.50	0.57	0.09	0.09	0.38	0.19	0.09	0.19
Keratinocyte - oral, donor1	11251-116E9	41.43	7.49	5.11	0.91	0.68	0.11	0.11	0.57	0.34	0.00
Keratocytes, donor1	11527-119I6	46.42	3.44	4.47	0.69	3.44	1.03	0.34	0.00	0.00	0.00
Keratocytes, donor2	11607-120I5	37.50	8.20	1.17	0.00	0.00	0.00	0.00	1.17	0.00	0.00
Keratocytes, donor3	11688-122I5	20.55	2.57	3.56	0.20	0.20	0.40	0.00	0.20	0.00	0.40
Krukenberg tumor cell line:HSKTC	10687-109F3	13.19	6.59	4.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	38.83	2.16	2.16	0.00	2.16	0.00	1.08	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	40.71	3.58	3.92	0.46	2.54	0.69	0.58	0.00	0.12	0.12
Lens Epithelial Cells, donor3	11690-122I7	37.24	2.42	3.73	0.91	0.30	0.10	0.10	0.10	0.10	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	29.88	2.02	1.90	0.47	1.07	0.24	0.12	0.24	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	22.61	1.40	1.40	0.28	0.28	0.00	0.56	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	27.07	3.46	1.10	0.31	0.94	0.16	0.47	0.47	0.00	0.16
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	22.05	1.08	1.61	0.54	0.54	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	26.16	3.47	1.89	0.00	0.63	0.32	0.32	0.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	25.77	1.73	1.08	0.32	0.54	0.11	0.75	0.22	0.11	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	18.06	2.05	0.00	0.00	0.00	0.00	0.41	0.00	0.41	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	19.47	2.02	1.01	0.25	0.76	0.00	0.76	0.00	0.51	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	22.94	1.83	1.41	0.56	0.42	0.56	0.70	0.14	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	16.61	1.58	1.19	1.19	0.79	0.40	0.00	0.00	0.40	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	17.64	1.16	1.55	0.00	0.19	0.00	0.00	0.19	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	25.74	1.48	1.85	0.37	0.00	0.19	0.37	0.37	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	19.86	0.70	2.44	0.35	0.35	0.35	0.70	0.70	0.00	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	26.24	2.86	1.19	0.00	0.95	0.00	0.00	0.00	0.00	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	26.10	1.92	1.37	0.27	0.96	0.41	0.96	0.27	0.00	0.14
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	20.02	0.92	1.23	0.31	0.31	0.31	1.54	0.31	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	25.87	1.25	1.87	0.94	0.31	0.00	0.62	0.31	0.00	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	33.49	2.56	1.10	0.37	0.55	0.18	0.18	0.18	0.18	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	27.65	1.65	0.00	0.00	1.32	0.66	0.33	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	24.31	2.64	2.05	0.29	0.59	0.00	0.29	0.00	0.29	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	26.64	2.24	1.00	1.00	0.75	0.00	1.00	0.00	0.50	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	22.79	3.39	0.97	0.48	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	21.01	0.81	1.62	0.00	0.54	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	25.43	1.97	1.67	0.45	1.36	0.00	0.91	0.15	0.00	0.45
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	27.99	2.07	1.56	0.00	0.00	0.00	0.00	0.52	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	22.20	1.05	1.47	0.00	0.63	0.21	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	26.32	2.26	1.80	0.15	0.75	0.15	0.60	0.30	0.15	0.30
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	20.64	0.69	0.00	0.69	0.00	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	19.94	1.32	0.94	0.00	0.38	0.00	0.00	0.38	0.00	0.19
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	23.43	1.59	1.48	0.32	0.85	0.11	0.42	0.21	0.11	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	20.84	2.42	1.94	0.48	0.00	0.00	0.48	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	20.84	1.98	0.33	0.33	0.00	0.00	0.99	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	25.77	1.98	2.23	0.12	1.24	0.00	0.99	0.12	0.00	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	21.84	3.33	1.48	0.37	0.74	0.37	0.00	0.37	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	15.07	0.74	0.99	0.25	0.25	0.25	0.00	0.00	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	23.24	2.06	1.10	0.27	0.41	0.14	0.82	0.27	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	24.44	2.57	1.61	0.00	0.32	0.32	0.32	0.32	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	24.65	1.83	1.22	0.00	0.00	0.00	0.30	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	21.41	1.54	1.40	0.14	0.70	0.28	0.28	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	19.56	0.71	2.13	0.00	0.71	0.36	0.36	0.36	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	18.42	1.45	0.48	0.00	0.48	0.00	0.48	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	28.63	1.56	2.02	0.31	0.78	0.16	1.24	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	20.77	1.79	2.15	0.00	0.36	0.00	0.36	0.36	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	23.52	0.33	1.96	0.33	0.33	0.00	0.00	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	24.01	1.65	0.47	0.24	0.47	0.00	0.47	0.00	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	35.64	1.73	2.48	0.37	0.74	0.25	0.37	0.74	0.00	0.12
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	19.21	1.54	1.54	0.00	0.26	0.26	0.26	0.00	0.26	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	17.90	1.79	1.49	0.00	0.00	0.30	0.60	0.30	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	31.72	4.53	9.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	50.63	7.67	6.14	1.53	0.00	0.00	1.53	0.77	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	41.56	8.91	5.20	2.23	0.74	0.00	0.00	1.48	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	54.58	5.50	3.39	0.42	0.85	0.00	1.27	0.85	0.42	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	49.94	8.44	4.92	0.70	0.00	0.00	0.00	0.70	0.70	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	41.09	3.74	2.80	2.80	0.00	0.00	1.87	0.93	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	41.22	6.18	1.03	0.52	0.52	0.52	3.61	1.03	0.52	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	53.53	5.95	2.38	2.38	0.00	0.00	1.19	1.19	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	41.62	5.65	3.85	0.23	0.23	0.00	0.23	0.45	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	35.77	3.20	3.20	0.58	0.00	0.00	2.04	0.29	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	33.31	9.00	4.50	2.25	1.35	0.00	2.25	0.45	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	62.73	12.87	4.20	0.81	0.54	0.00	0.81	0.95	0.00	0.14
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	55.46	8.73	3.59	1.54	0.00	0.00	2.57	1.03	0.51	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	41.28	9.17	6.35	1.06	0.35	0.00	1.06	0.00	0.00	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	30.65	8.00	2.00	0.67	0.00	0.00	0.67	0.00	0.00	1.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	53.99	5.60	4.58	1.02	0.51	0.00	1.53	2.04	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	45.36	5.87	6.67	0.27	0.53	0.00	0.53	0.80	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	48.94	6.99	4.91	0.19	0.76	0.00	0.94	0.19	0.00	0.38
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	44.18	3.68	1.23	1.23	0.00	0.00	6.14	0.61	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	56.26	7.34	10.60	2.45	0.82	0.00	2.45	0.82	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	49.15	9.16	3.96	0.83	0.83	0.21	2.71	1.46	0.42	0.21
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	36.43	4.20	2.24	0.56	0.28	0.00	0.84	0.28	0.84	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	46.37	13.39	10.30	2.06	0.00	0.00	1.03	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	47.32	7.55	6.68	0.58	1.45	0.00	3.19	1.16	0.00	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	40.06	5.68	2.99	0.60	0.00	0.00	1.49	0.30	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	52.01	6.64	2.21	0.55	0.55	0.00	0.55	1.66	0.00	0.55
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	71.05	10.96	5.66	1.06	0.35	0.35	2.83	1.41	0.00	0.71
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	40.93	7.01	6.27	0.74	0.00	0.00	2.58	0.74	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	46.05	8.06	9.21	1.15	0.00	0.00	1.15	2.30	0.00	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	51.42	9.21	5.76	0.38	0.00	0.00	0.77	0.77	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	43.03	5.66	2.26	0.57	1.13	1.13	2.83	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	45.13	7.38	3.28	1.64	0.82	0.00	0.82	0.82	0.00	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	58.29	9.49	7.68	1.36	0.90	0.00	2.71	0.00	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	50.99	5.03	0.72	0.00	0.00	0.00	2.15	0.72	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	44.81	7.47	5.98	3.73	0.75	0.75	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	57.23	10.03	6.69	2.23	0.74	0.00	4.83	1.49	0.37	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	35.75	4.31	2.58	0.00	0.43	0.00	0.86	1.29	0.00	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	43.67	5.14	5.14	2.57	0.00	0.00	0.86	1.71	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	56.97	10.99	7.00	1.00	0.33	0.33	3.33	0.67	0.33	0.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	44.64	9.05	2.41	0.00	1.21	0.00	1.21	0.60	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	42.66	7.11	4.27	0.71	0.71	0.00	1.42	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	60.15	9.97	6.87	2.06	0.00	0.34	4.81	0.00	0.34	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	52.06	2.68	3.22	0.54	0.00	0.00	1.61	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	48.48	6.73	5.39	1.35	0.00	0.00	0.00	3.37	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	61.49	8.52	5.93	1.85	0.74	0.37	2.22	0.37	1.11	0.37
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	31.40	4.65	2.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	56.06	6.35	6.35	0.00	0.00	1.06	1.06	1.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	52.42	8.00	7.60	2.00	0.00	0.00	2.00	0.80	0.40	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	51.61	4.36	2.91	0.73	0.73	0.00	0.73	0.00	0.73	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	59.79	13.80	2.30	2.30	0.00	0.00	0.77	1.53	0.77	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	67.09	8.39	7.40	0.00	0.00	0.00	2.96	0.49	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	47.99	1.88	4.70	0.94	0.94	0.94	4.70	1.88	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	55.81	10.06	9.05	1.51	0.50	0.00	1.01	0.50	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	66.69	8.56	5.41	0.90	0.00	0.00	2.70	0.90	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	49.91	1.72	0.00	0.00	0.00	0.00	8.61	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	56.11	8.91	7.57	1.34	0.45	0.00	1.78	0.45	0.45	0.89
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	73.12	10.95	9.78	0.78	0.39	0.00	3.52	0.39	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	38.26	6.60	3.30	1.98	0.66	0.00	2.64	0.00	0.66	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	60.71	7.26	8.30	2.08	1.04	0.00	0.52	0.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	78.76	8.75	6.13	1.75	1.31	0.88	4.38	1.31	0.44	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	54.23	5.59	2.80	0.56	1.12	0.00	0.00	1.68	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	63.60	9.72	9.27	1.77	2.65	0.00	1.32	0.88	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	49.76	10.41	6.94	2.70	0.39	0.00	1.54	0.77	0.39	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	52.15	6.08	1.52	2.03	0.00	0.00	2.03	1.01	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	54.31	6.25	6.25	0.00	0.96	0.00	2.40	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	64.40	7.95	5.96	0.40	0.80	0.00	1.19	1.19	0.40	0.80
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	45.57	3.04	6.68	0.00	0.00	0.00	0.61	1.22	0.00	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	44.96	8.99	4.84	1.38	0.00	0.00	1.38	0.69	0.69	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	58.52	9.12	6.84	0.76	0.76	0.00	4.56	0.00	1.14	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	49.06	0.00	2.58	0.52	0.00	0.00	2.07	1.55	0.00	0.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	50.19	3.63	7.86	1.21	0.00	0.00	1.21	0.60	0.60	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	55.77	7.92	8.56	1.27	0.63	0.00	2.54	1.58	0.63	0.63
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	63.44	4.80	3.73	0.00	0.00	0.00	3.20	1.07	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	44.82	4.02	3.45	1.72	0.00	0.00	1.15	2.30	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	55.02	10.80	3.09	1.54	0.00	0.00	1.54	1.03	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	68.61	5.66	3.54	0.71	1.41	0.00	2.12	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	64.13	3.97	2.84	0.57	1.13	0.00	0.57	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	58.24	6.66	7.49	0.42	0.00	0.00	3.33	0.42	0.42	0.83
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	54.03	7.05	0.78	1.57	0.00	0.00	2.35	2.35	0.78	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	53.86	5.01	5.01	0.00	0.84	0.00	2.09	0.42	0.00	0.84
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	67.84	9.29	6.50	2.79	0.46	0.46	0.93	0.93	0.00	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	50.18	8.70	2.68	0.67	0.67	0.00	2.68	0.67	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	72.18	3.74	7.48	0.00	0.53	0.00	1.07	0.53	0.53	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	79.20	11.31	7.68	2.83	0.81	0.00	4.04	2.42	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	61.49	0.92	2.75	0.00	0.00	0.92	1.84	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	65.79	5.33	4.45	0.00	0.00	0.89	2.67	2.67	0.00	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	85.48	13.11	7.98	1.71	0.00	0.00	2.85	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	55.98	2.30	3.83	0.00	0.00	0.00	2.30	0.77	1.53	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	58.00	2.19	6.57	0.00	0.55	0.00	3.83	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	84.63	8.02	5.79	1.34	0.45	0.00	1.78	0.45	0.45	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	73.31	5.72	7.28	0.26	0.26	0.00	1.82	0.52	0.26	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	72.94	3.98	5.30	2.65	0.66	0.00	0.66	2.65	0.66	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	85.22	4.16	8.31	0.00	0.00	0.00	2.08	2.08	2.08	0.00
Macrophage - monocyte derived, donor1	11232-116C8	14.36	5.01	1.14	0.00	0.68	0.00	0.00	0.00	0.00	0.23
Macrophage - monocyte derived, donor2	11313-117C8	12.29	4.95	1.84	0.00	0.92	0.00	0.18	0.00	0.18	0.00
Macrophage - monocyte derived, donor3	11389-118C3	14.42	6.03	2.36	0.66	1.31	0.00	0.39	0.13	0.00	0.00
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	9.03	1.59	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	16.95	1.43	0.95	0.32	0.95	0.00	0.00	0.16	0.00	0.32
Mallassez-derived cells, donor3	11930-125I4	20.71	1.53	1.25	0.56	0.56	0.00	0.14	0.14	0.14	0.28
Mammary Epithelial Cell, donor1	11273-116H4	26.80	2.69	3.09	0.40	0.60	0.00	0.10	0.00	0.20	0.10
Mammary Epithelial Cell, donor2	11350-117G9	26.64	2.90	1.45	0.00	0.00	0.58	0.29	0.58	0.00	0.29
Mammary Epithelial Cell, donor3	11422-118F9	34.92	1.50	5.24	0.75	0.75	0.00	0.00	0.00	0.00	0.25
Mast cell - stimulated, donor1	11487-119E2	8.81	0.00	0.68	1.36	0.00	0.68	0.00	0.00	0.00	0.00
Mast cell, donor1	11563-120D6	31.14	6.60	3.78	1.30	1.51	0.22	0.76	0.65	0.54	0.00
Mast cell, donor2	11565-120D8	27.93	20.21	1.78	2.08	0.59	0.59	0.30	1.78	0.30	0.30
Mast cell, donor3	11566-120D9	22.29	14.63	2.93	1.35	1.58	0.45	0.00	2.70	0.68	0.00
Mast cell, donor4	11567-120E1	25.35	17.55	4.79	1.60	0.18	0.00	0.18	2.30	0.00	0.18
Mast cell, expanded and stimulated, donor5	11940-126A5	26.28	7.87	2.00	1.00	0.67	0.11	0.11	1.44	0.33	0.11
Mast cell, expanded and stimulated, donor8	11942-126A7	27.43	3.50	1.17	0.00	1.17	0.00	0.58	1.17	0.00	0.00
Mast cell, expanded, donor5	11939-126A4	24.67	3.67	1.15	0.57	1.03	0.00	0.00	1.03	0.34	0.00
Mast cell, expanded, donor8	11941-126A6	25.61	8.20	1.84	0.84	1.34	0.17	0.17	2.34	0.50	0.00
Melanocyte - dark, donor1	11502-119F8	15.82	2.59	2.39	0.80	0.30	0.20	0.30	0.10	0.00	0.00
Melanocyte - dark, donor2	11582-120F7	19.73	2.42	1.38	1.04	1.04	0.69	1.04	0.00	0.35	0.35
Melanocyte - dark, donor3	11663-122F7	47.96	3.62	4.49	0.80	1.81	0.29	0.22	0.72	0.14	0.22
Melanocyte - light, donor1	11274-116H5	40.43	3.76	3.53	0.47	1.65	0.24	0.24	0.71	0.71	0.00
Melanocyte - light, donor2	11351-117H1	40.95	2.05	1.36	2.05	2.05	0.68	0.00	2.73	1.36	0.00
Melanocyte - light, donor3	11423-118G1	32.95	2.60	3.47	0.87	0.00	0.00	0.00	0.87	0.00	0.87
Melanocyte, donor1 (MC+1)	12641-134G4	34.88	3.54	3.33	1.15	0.94	0.21	0.94	0.10	0.21	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	27.97	1.88	1.88	0.00	0.54	0.27	0.27	0.00	0.00	0.00
Melanocyte, donor3 (MC+3)	12837-137B2	36.16	5.09	3.75	0.54	2.95	1.34	0.54	0.27	0.00	0.00
Meningeal Cells, donor1	11493-119E8	89.57	4.22	4.59	1.24	1.24	1.12	0.37	1.24	0.25	0.12
Meningeal Cells, donor2	11573-120E7	73.94	3.08	5.72	0.00	0.00	1.32	0.00	0.44	0.00	0.00
Meningeal Cells, donor3	11654-122E7	42.46	2.93	2.28	0.33	0.73	0.16	0.49	0.00	0.00	0.08
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	19.68	6.27	2.57	0.86	0.86	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	22.04	2.11	1.91	0.70	1.11	0.20	0.30	0.20	0.00	0.10
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	9.20	1.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	31.40	5.23	2.62	1.31	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	26.55	1.44	2.15	0.00	0.00	0.00	0.72	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	17.58	4.24	2.12	0.85	1.06	0.42	0.21	0.64	0.21	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	14.58	3.52	2.01	0.50	1.51	0.00	1.51	0.50	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	48.79	8.57	3.52	0.44	1.10	0.66	0.22	0.22	0.00	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	52.60	5.84	4.38	0.73	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	52.79	4.09	4.71	0.82	0.82	0.61	0.00	0.61	0.41	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	13.44	1.52	0.97	0.14	1.11	0.14	0.28	0.00	0.14	0.14
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	31.22	8.18	1.12	0.00	1.49	0.37	0.37	0.37	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	19.60	3.16	1.84	0.53	0.79	0.26	0.26	0.00	0.13	0.13
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	17.51	3.26	0.89	0.89	0.30	0.00	0.00	0.30	0.30	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	9.34	4.67	2.34	0.00	0.00	2.34	0.00	2.34	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	45.47	5.76	3.84	1.92	0.64	0.00	0.00	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	29.42	2.13	1.06	0.00	0.35	0.00	0.35	0.00	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	16.57	2.50	2.19	0.31	0.63	0.00	0.31	0.00	0.00	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	21.77	4.35	5.81	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesothelial Cells, donor1	11247-116E5	15.65	0.53	1.06	0.27	1.06	0.53	0.00	0.80	0.00	0.00
Mesothelial Cells, donor2	12156-128G5	15.01	2.00	1.00	0.00	0.00	0.00	0.00	0.00	0.00	0.50
Mesothelial Cells, donor3	11402-118D7	19.37	1.73	1.45	0.43	0.72	0.22	0.22	0.22	0.14	0.14
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	16.20	8.10	1.35	2.70	1.35	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	18.22	6.65	0.74	0.49	0.74	0.25	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	16.20	3.83	1.18	0.59	0.88	0.00	0.00	1.18	0.59	0.29
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	34.57	10.37	10.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	13.02	4.65	1.24	0.31	0.00	0.31	0.31	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	9.33	4.15	0.83	0.00	0.41	0.00	0.21	0.21	0.21	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	30.11	9.26	2.32	0.00	4.63	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	13.51	3.75	1.75	0.50	0.50	0.50	0.25	0.25	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	20.02	3.26	0.47	0.47	0.93	0.93	0.47	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	58.40	19.47	0.00	19.47	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	13.82	4.47	1.02	0.41	0.20	0.41	0.20	0.00	0.00	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	17.82	4.75	0.79	0.00	1.19	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	8.55	25.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	3.54	2.65	0.00	0.88	0.00	0.00	0.88	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	14.44	1.14	0.38	0.00	0.76	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	18.42	7.90	2.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	8.70	4.24	0.42	0.42	0.64	0.00	0.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	11.05	1.84	0.00	0.00	2.76	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	10.73	2.68	0.89	0.30	0.30	0.30	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	20.12	0.00	1.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	33.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	8.78	2.26	1.00	0.25	0.50	0.00	0.25	0.00	0.00	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	14.26	2.85	0.24	0.24	0.48	0.24	0.24	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	23.22	3.87	1.66	0.55	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	8.75	2.53	0.46	0.00	0.23	0.00	0.23	0.00	0.23	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	11.57	4.00	1.26	0.42	0.00	0.21	0.00	0.21	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	7.95	3.67	1.22	0.00	0.20	0.00	0.00	0.20	0.00	0.20
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	8.80	2.36	0.64	0.43	0.43	0.00	0.00	0.00	0.00	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	13.78	4.22	0.44	0.89	0.22	0.00	0.00	0.22	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	41.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	9.42	2.63	0.66	0.44	0.22	0.00	0.22	0.00	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	10.65	2.53	1.52	1.01	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	16.57	6.63	1.66	1.66	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	7.88	2.72	1.63	0.82	0.27	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	13.82	2.35	0.59	0.00	0.59	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	6.54	2.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.09
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	3.36	0.00	0.00	0.00	0.48	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	12.41	1.60	0.80	0.40	0.80	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	6.86	8.23	1.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	8.01	2.00	1.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	14.27	2.04	2.04	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	7.01	1.31	0.00	0.88	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	23.18	4.41	1.10	0.00	1.10	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	13.45	4.48	0.64	1.28	0.00	0.00	0.00	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	5.70	1.98	0.25	0.00	0.00	0.00	0.25	0.00	0.00	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	16.70	4.18	0.70	0.70	1.39	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	15.47	2.21	2.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	5.81	2.39	0.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	10.94	3.50	1.31	1.31	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	9.59	3.55	1.42	0.71	0.00	0.00	0.36	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	6.45	3.09	0.84	0.56	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	10.39	2.49	0.83	0.42	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	15.15	4.66	1.17	1.17	0.58	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	7.84	4.22	1.51	0.30	0.30	0.00	0.00	0.00	0.00	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	7.10	1.25	1.25	0.83	0.00	0.00	0.42	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	21.66	7.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	10.16	1.85	0.92	0.92	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	8.54	3.41	0.57	1.14	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	14.92	3.87	1.24	0.41	0.00	0.00	0.28	0.00	0.28	0.28
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	5.96	2.07	0.26	0.26	0.00	0.00	0.78	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	12.44	4.29	3.00	0.00	0.43	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	13.34	4.45	1.91	0.00	1.27	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	12.01	4.27	1.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	12.57	2.39	1.50	0.60	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	12.15	4.10	1.55	0.28	0.14	0.14	0.00	0.00	0.00	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	7.64	1.91	0.32	0.64	0.00	0.00	0.32	0.96	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	8.62	0.88	1.33	0.66	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	12.51	3.41	0.38	0.00	0.38	0.00	0.00	0.00	0.00	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	7.39	2.84	0.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	12.29	2.95	1.72	0.25	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	19.55	3.91	0.00	0.65	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	15.58	3.23	1.47	0.29	0.29	0.29	0.29	0.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	14.13	3.75	1.44	0.58	0.86	0.00	0.29	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	16.90	3.71	0.41	0.00	0.41	0.82	0.00	0.00	0.41	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	15.48	4.47	2.08	0.60	0.89	0.60	0.30	0.30	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	7.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	3.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	9.53	2.96	0.33	0.33	1.31	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	8.42	3.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	6.92	2.17	0.59	0.00	0.40	0.00	0.20	0.20	0.00	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	9.31	2.79	2.79	0.00	0.93	0.93	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	10.51	4.13	0.38	0.00	0.38	0.00	0.38	0.75	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	7.19	4.26	0.00	0.53	0.80	0.00	0.27	0.27	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	4.30	3.96	0.68	0.34	0.23	0.00	0.00	0.11	0.00	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	8.10	4.42	0.74	0.74	0.00	0.00	0.74	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	8.79	4.76	1.10	0.37	0.37	0.00	0.37	0.37	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	14.00	0.00	1.56	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	1.60	1.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	3.86	3.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00	3.86
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	9.09	1.01	1.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	5.90	2.11	0.84	0.00	0.84	0.42	0.00	0.00	0.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	2.72	1.36	1.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	0.64	0.00	0.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	0.81	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	3.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	5.71	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	9.79	3.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	14.26	4.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	12.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	21.33	3.45	1.51	0.22	0.43	0.22	0.65	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	13.07	3.66	2.61	0.52	1.57	0.00	0.52	0.00	0.52	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	47.39	1.33	2.67	0.00	0.67	0.00	0.00	0.00	1.33	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	46.75	1.67	5.01	0.42	1.25	0.42	0.42	0.42	0.42	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	38.41	3.04	4.94	0.95	0.38	0.19	0.00	0.38	0.00	0.38
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	75.01	3.19	3.19	1.60	1.60	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	28.56	0.00	0.00	0.00	0.68	0.68	0.00	0.68	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	11.03	0.00	1.84	0.00	0.00	1.84	1.84	1.84	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	20.51	0.84	1.67	0.42	0.84	0.00	0.00	0.42	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	35.56	1.63	0.46	0.46	0.93	0.00	0.00	0.00	0.23	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	30.27	0.27	1.35	0.27	1.35	0.00	0.00	0.27	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	31.54	2.31	2.31	0.42	1.05	0.21	0.21	0.21	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	11.13	11.13	11.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	19.85	0.50	0.99	0.00	0.50	0.50	0.00	0.00	1.49	0.50
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	10.01	0.81	0.81	0.00	0.54	0.00	0.54	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	16.77	0.91	1.36	0.23	1.36	0.45	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	28.90	1.31	1.14	0.49	1.96	0.16	0.00	0.16	0.16	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	20.96	1.82	2.37	0.18	0.36	0.00	0.18	0.55	0.00	0.36
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	22.81	1.06	2.12	0.53	0.00	0.00	0.00	0.00	0.53	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	19.21	0.60	0.00	0.60	1.80	0.00	0.00	0.60	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	10.83	0.98	1.31	0.00	0.00	0.66	0.33	0.98	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	22.28	0.33	0.98	0.49	1.30	0.33	0.00	0.16	0.33	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	36.33	1.94	1.06	1.06	0.71	0.00	0.18	0.00	0.35	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	26.02	0.70	0.70	0.00	2.81	0.00	0.70	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	28.50	1.38	0.92	0.00	2.30	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	18.32	2.25	0.96	0.00	0.32	0.32	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	14.49	1.38	0.34	0.69	0.34	0.69	0.00	0.34	0.34	0.34
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	17.70	0.00	0.00	0.00	0.00	0.00	0.00	2.53	2.53	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	30.74	1.56	2.45	0.00	0.45	0.00	0.00	0.00	0.22	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	22.44	1.69	0.42	0.85	1.69	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	14.72	3.32	1.90	0.00	1.42	0.24	0.00	0.47	0.24	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	17.60	0.86	0.86	0.86	0.43	0.43	0.00	0.86	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	9.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	30.99	1.33	1.33	0.67	1.33	0.33	0.00	0.00	0.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	29.76	1.35	0.45	0.45	1.35	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	23.41	0.00	1.19	0.40	0.40	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	26.93	0.93	0.00	0.93	0.93	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	20.81	2.27	1.89	0.76	0.76	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	21.51	0.33	1.30	0.00	1.96	0.00	0.33	0.33	0.33	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	33.56	2.61	1.74	0.44	0.87	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	42.51	1.81	2.26	0.00	1.81	0.00	0.00	0.00	0.00	0.90
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	15.87	0.00	0.00	0.00	0.88	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	12.63	0.00	0.66	0.66	0.00	0.00	0.00	0.00	0.66	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	26.29	0.50	0.99	0.00	2.98	0.50	0.00	0.50	0.50	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	21.06	0.77	1.91	0.00	0.38	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	22.08	3.02	1.21	0.30	0.60	0.60	0.60	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	23.65	1.77	0.66	0.44	0.88	0.22	0.22	0.00	0.00	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	19.65	2.03	0.00	0.68	4.07	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	10.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	15.85	1.22	0.61	0.61	0.61	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	18.57	3.78	3.78	0.31	1.89	0.00	0.00	0.00	0.31	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	33.29	1.21	3.93	0.61	0.91	0.30	0.30	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	18.99	0.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	7.94	4.53	4.53	1.13	1.13	1.13	1.13	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	5.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	14.29	2.36	2.36	0.12	0.62	0.12	0.50	0.12	0.00	0.25
Myoblast, donor2	11322-117D8	29.54	3.84	3.26	0.77	0.00	0.19	1.15	0.38	0.00	0.00
Myoblast, donor3	11398-118D3	34.14	3.70	3.53	0.67	0.50	0.17	0.00	0.17	0.00	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	45.09	12.84	4.96	1.75	0.58	0.58	1.02	0.00	0.15	0.15
Natural Killer Cells, donor1	11230-116C6	19.37	13.84	3.08	0.62	0.31	0.00	0.00	0.00	0.31	0.00
Natural Killer Cells, donor2	11311-117C6	16.89	10.25	2.11	1.51	0.30	0.00	0.60	0.60	0.30	0.00
Natural Killer Cells, donor3	11387-118C1	20.61	14.17	2.02	0.37	0.00	0.00	0.00	0.37	0.18	0.00
Neural stem cells, donor1	11275-116H6	115.05	6.53	5.08	0.73	3.27	0.00	2.18	2.18	0.73	0.36
Neural stem cells, donor2	11352-117H2	204.12	5.78	5.78	3.85	3.85	1.93	0.00	0.00	1.93	1.93
Neurons, donor1	11494-119E9	116.07	5.69	5.69	1.14	1.14	0.00	2.28	0.00	0.00	0.00
Neurons, donor2	11574-120E8	106.78	5.28	3.96	0.22	0.88	0.66	0.00	0.66	0.00	0.00
Neurons, donor3	11655-122E8	83.04	4.11	0.82	0.82	0.00	0.00	9.04	0.82	0.82	0.82
Neutrophils, donor1	11233-116C9	4.64	4.64	0.00	0.00	0.00	0.00	0.00	0.93	0.00	0.00
Neutrophils, donor2	11314-117C9	2.90	8.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	5.50	4.89	0.61	0.00	0.00	0.00	0.00	0.00	0.61	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	12.23	3.32	0.71	0.36	2.02	0.83	0.24	0.00	0.00	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	14.33	1.95	0.33	0.33	1.30	0.33	0.65	0.00	0.00	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	11.23	1.00	1.00	0.20	0.20	0.00	0.20	0.00	0.00	0.00
Olfactory epithelial cells, donor1	11933-125I7	11.01	1.79	0.83	0.00	0.28	0.28	0.83	0.00	0.14	0.00
Olfactory epithelial cells, donor2	11934-125I8	13.17	2.46	1.45	0.43	0.29	0.14	0.58	0.14	0.14	0.00
Olfactory epithelial cells, donor3	11935-125I9	12.60	1.48	1.14	0.57	0.68	0.23	0.45	0.00	0.11	0.00
Olfactory epithelial cells, donor4	11936-126A1	19.48	1.95	2.24	0.29	0.97	0.19	0.10	0.10	0.19	0.19
Oligodendrocyte - precursors, donor1	11496-119F2	28.89	4.81	3.61	1.20	0.60	0.00	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	15.10	2.98	1.28	0.64	0.43	0.43	0.21	0.64	0.21	0.00
Osteoblast - differentiated, donor2	11353-117H3	6.86	0.00	1.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	8.69	1.86	0.62	0.00	1.24	0.00	0.00	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	35.57	3.71	2.93	0.20	1.17	0.98	0.00	1.17	0.00	0.00
Osteoblast, donor2	11354-117H4	43.54	3.51	2.81	0.70	0.70	0.00	1.40	0.00	0.70	0.00
Osteoblast, donor3	11426-118G4	43.54	4.80	4.62	0.89	0.89	0.36	0.00	0.18	0.18	0.00
Pancreatic stromal cells, donor1	11249-116E7	20.47	3.20	1.10	0.67	1.01	0.25	0.08	0.25	0.25	0.00
Pericytes, donor1	11491-119E6	22.25	6.34	1.34	0.67	2.34	0.67	0.33	0.22	0.11	0.22
Pericytes, donor2	11571-120E5	40.29	7.70	3.40	0.68	0.68	0.45	0.68	0.45	0.00	0.00
Pericytes, donor3	11652-122E5	29.91	2.44	3.05	0.00	0.20	0.00	0.61	0.41	0.20	0.41
Perineurial Cells, donor1	11499-119F5	33.45	3.28	3.73	0.57	0.79	0.11	0.11	0.00	0.00	0.23
Perineurial Cells, donor2	11579-120F4	23.92	3.22	2.76	0.55	0.83	0.46	0.00	0.09	0.09	0.09
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	21.67	13.07	2.87	0.96	0.64	0.00	0.00	0.32	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	15.67	9.06	0.73	0.73	0.73	0.24	0.24	0.98	0.00	0.24
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	17.60	10.22	1.94	0.91	1.04	0.00	0.39	0.13	0.13	0.00
Placental Epithelial Cells, donor1	11278-116H9	11.96	8.61	3.11	0.48	0.00	0.24	0.24	0.00	0.72	0.00
Placental Epithelial Cells, donor2	11355-117H5	22.18	2.22	2.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	28.47	5.10	2.16	1.18	0.39	0.39	0.39	0.79	0.00	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	3.48	0.95	0.63	0.32	0.00	0.00	0.00	0.32	0.00	0.00
Preadipocyte - breast, donor1	11467-119B9	5.44	1.13	0.56	0.00	0.38	0.19	0.38	0.19	0.00	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	23.10	7.44	4.57	1.44	0.39	0.00	0.39	0.26	0.00	0.00
Preadipocyte - breast, donor2	11328-117E5	10.13	4.50	1.80	0.45	0.23	0.45	0.68	0.00	0.00	0.00
Preadipocyte - omental, donor1	11468-119C1	9.59	2.34	0.43	0.43	0.53	0.11	0.11	0.53	0.11	0.00
Preadipocyte - omental, donor2	11329-117E6	11.35	3.49	2.18	0.44	0.87	0.00	1.31	0.44	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	16.76	2.01	1.58	0.86	1.15	0.14	0.29	0.72	0.00	0.00
Preadipocyte - perirenal, donor1	11469-119C2	7.87	0.00	1.97	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	29.18	2.15	3.69	1.54	1.54	0.31	0.00	0.92	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	40.20	4.96	3.36	0.89	0.89	0.35	1.42	0.89	0.00	0.35
Preadipocyte - subcutaneous, donor3	11428-118G6	25.71	1.19	4.77	0.85	0.85	0.00	0.51	0.17	1.19	0.00
Preadipocyte - visceral, donor1	11280-116I2	32.97	2.89	1.86	0.37	0.37	0.19	0.28	0.28	0.37	0.19
Preadipocyte - visceral, donor2	11357-117H7	35.89	2.30	4.60	0.00	0.46	0.00	1.38	0.00	0.00	0.00
Preadipocyte - visceral, donor3	11429-118G7	26.44	2.72	3.55	0.52	0.63	0.52	0.42	0.10	0.10	0.21
Prostate Epithelial Cells (polarized), donor1	11253-116F2	47.37	4.37	4.83	0.60	0.75	0.45	0.45	1.96	0.60	0.00
Prostate Epithelial Cells, donor2	11331-117E8	27.62	1.49	2.44	0.41	0.54	0.00	0.81	1.22	1.22	0.00
Prostate Epithelial Cells, donor3	11404-118D9	14.57	6.00	3.18	0.73	0.12	0.00	0.73	0.24	0.43	0.12
Prostate Stromal Cells, donor1	11254-116F3	26.20	2.51	2.39	0.11	0.34	0.34	0.23	0.34	0.23	0.11
Prostate Stromal Cells, donor2	11332-117E9	25.82	3.41	1.26	0.18	0.18	0.18	1.08	0.72	0.00	0.18
Prostate Stromal Cells, donor3	11405-118E1	14.29	2.61	1.56	0.83	0.73	0.10	0.31	0.10	0.42	0.21
Renal Cortical Epithelial Cells, donor1	11516-119H4	66.79	12.77	6.20	1.46	1.09	0.00	0.36	0.73	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	31.05	3.26	1.94	0.35	0.07	0.00	0.28	0.14	0.07	0.07
Renal Epithelial Cells, donor1	11517-119H5	71.52	6.59	6.09	1.01	0.51	0.00	0.00	0.00	0.51	0.00
Renal Epithelial Cells, donor2	11597-120H4	71.13	4.27	3.56	1.42	2.85	0.00	0.00	1.42	0.00	0.71
Renal Epithelial Cells, donor3	11678-122H4	39.91	4.45	1.91	0.32	0.32	0.00	0.74	0.32	0.00	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	34.72	6.81	1.36	0.68	2.72	0.68	2.04	0.68	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	44.20	2.02	4.18	0.27	0.54	0.67	0.40	0.13	0.27	0.40
Renal Glomerular Endothelial Cells, donor3	11675-122H1	46.18	4.66	4.44	0.67	0.44	0.00	0.44	0.22	0.89	0.00
Renal Glomerular Endothelial Cells, donor4	11783-124B1	37.26	3.99	4.66	1.33	0.67	0.00	0.67	0.00	0.67	0.00
Renal Mesangial Cells, donor1	11518-119H6	57.00	8.36	1.98	0.44	0.88	0.22	0.44	0.00	0.22	0.22
Renal Mesangial Cells, donor2	11598-120H5	64.58	9.40	2.51	1.25	0.63	0.00	0.00	0.63	0.63	0.00
Renal Mesangial Cells, donor3	11679-122H5	46.88	5.55	3.61	0.83	0.55	0.00	0.83	0.55	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	49.39	9.13	3.76	0.81	0.27	0.00	0.54	0.00	0.00	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	25.72	6.33	1.27	0.42	0.42	0.00	0.00	0.00	0.42	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	64.41	5.98	3.86	1.16	1.35	0.39	0.39	0.39	0.39	0.19
Retinal Pigment Epithelial Cells, donor0	11215-116A9	35.26	8.56	3.11	0.52	1.30	1.04	0.00	0.00	0.00	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	56.56	7.39	4.26	1.14	1.42	0.57	0.57	0.28	0.57	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	44.25	3.09	6.17	3.09	0.00	0.00	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	16.31	3.76	1.25	0.50	0.00	0.00	0.00	0.00	0.25	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	11.36	7.35	0.94	0.67	1.74	0.00	0.27	0.13	0.40	0.13
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	46.46	2.68	0.89	0.00	0.89	0.89	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	35.22	0.55	2.75	0.55	2.75	0.55	2.20	1.65	0.55	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	41.18	2.32	2.90	0.58	0.00	0.00	0.58	0.58	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	66.18	2.08	5.85	0.52	0.65	0.65	0.26	1.04	0.13	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	69.22	3.48	6.16	0.79	0.89	0.40	1.39	0.60	0.20	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	63.02	2.68	5.80	1.23	0.78	0.22	0.11	0.33	0.22	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	51.11	3.72	7.19	1.36	1.24	0.37	1.74	0.62	0.12	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	68.88	2.68	7.46	1.05	1.63	0.70	1.28	0.70	0.35	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	72.81	3.70	2.54	1.16	0.23	0.46	1.16	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	60.65	2.60	6.57	1.23	0.96	1.10	0.41	0.14	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	58.54	3.18	6.96	1.21	1.66	0.61	1.82	0.15	0.00	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	58.77	4.30	4.84	0.72	0.72	0.54	0.18	0.54	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	58.10	3.16	5.02	2.01	0.43	0.57	1.00	0.14	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	54.84	3.00	5.90	0.64	1.40	0.43	0.97	0.64	0.11	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	62.40	2.43	3.98	1.33	1.11	0.89	0.44	0.44	0.00	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	58.31	1.72	4.21	0.76	0.38	0.38	0.76	0.19	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	64.84	3.07	7.36	0.84	0.75	0.28	1.12	0.37	0.09	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	65.02	3.76	3.38	0.94	1.32	0.38	0.00	0.75	0.00	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	62.37	2.79	6.37	1.06	0.66	0.66	0.93	0.27	0.00	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	70.47	4.58	8.47	1.27	0.88	0.39	0.39	0.49	0.29	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	62.06	4.77	8.21	0.95	0.76	0.00	0.57	0.19	0.19	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	67.92	1.82	6.41	1.60	0.75	0.21	0.32	0.21	0.11	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	59.42	3.64	4.20	1.12	0.84	0.84	1.68	0.84	0.56	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	65.62	2.91	4.96	0.68	0.51	0.34	2.22	0.85	0.17	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	61.08	2.55	5.65	1.09	0.73	0.36	0.00	0.36	0.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	66.47	4.05	6.87	0.98	1.10	0.74	1.47	0.86	0.12	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	65.28	3.49	6.04	1.21	1.34	0.27	0.67	0.13	0.27	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	58.26	2.59	4.95	0.24	0.94	0.24	0.71	0.00	0.71	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	73.61	3.77	6.15	0.99	0.99	0.20	1.59	0.79	0.20	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	61.97	3.04	6.78	0.94	0.94	0.00	1.17	0.23	0.23	0.23
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	50.39	2.07	6.64	1.04	0.41	0.21	1.24	0.41	0.62	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	60.83	3.10	5.09	0.88	1.11	0.44	2.65	1.11	0.22	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	59.11	4.18	7.31	0.00	0.63	0.42	0.84	0.21	0.21	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	63.12	3.23	7.40	2.02	1.35	0.54	0.94	0.27	0.00	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	73.23	3.92	9.03	0.85	0.34	0.34	0.51	0.17	0.34	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	70.37	5.59	6.75	1.35	0.39	0.00	1.54	0.00	0.19	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	49.00	3.61	5.67	1.20	1.20	1.03	0.69	0.34	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	62.14	7.27	7.41	1.65	0.96	0.55	0.69	0.27	0.14	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	58.44	4.60	3.28	0.99	0.99	0.82	1.48	0.82	0.66	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	57.61	2.05	5.45	1.19	1.02	0.51	1.19	0.34	0.34	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	61.70	4.73	6.81	1.18	1.18	0.15	0.89	0.30	0.15	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	57.31	3.47	6.13	0.53	0.80	0.27	0.27	1.07	0.53	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	53.23	3.46	4.98	0.69	0.69	0.69	0.28	0.83	0.41	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	48.81	3.57	5.48	0.24	1.90	0.48	0.71	0.71	0.48	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	80.01	6.05	8.06	1.01	1.61	0.40	0.60	0.81	0.40	0.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	40.40	3.48	4.24	0.75	1.60	0.57	0.85	0.47	0.09	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	50.66	2.45	2.79	0.00	3.49	1.05	1.40	1.05	0.70	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	41.10	3.63	6.35	0.60	3.02	0.60	1.21	0.30	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	35.98	1.84	4.90	0.24	1.22	0.12	0.86	0.73	0.37	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	73.94	7.86	6.99	0.58	1.89	0.73	0.29	1.02	0.15	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	40.76	3.65	4.26	0.00	1.22	1.22	0.00	0.00	0.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	36.77	1.81	3.92	0.30	1.21	0.60	0.30	0.30	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	36.19	4.52	2.04	0.90	2.94	1.36	1.13	1.13	1.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	45.53	3.59	3.89	1.20	1.20	0.60	0.30	0.00	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	37.08	2.36	4.13	0.12	1.42	0.24	0.59	1.53	1.06	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	43.97	4.06	5.34	0.85	2.13	0.64	1.07	2.35	0.85	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	47.48	5.41	6.01	0.00	1.80	0.00	0.60	0.60	0.60	0.60
Schwann Cells, donor1	11498-119F4	51.16	4.70	3.01	0.56	0.94	0.38	0.75	0.75	0.38	0.19
Schwann Cells, donor2	11578-120F3	34.02	6.80	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	35.71	2.41	2.63	1.10	0.88	0.22	1.53	0.22	0.00	0.00
Sebocyte, donor1	11220-116B5	79.97	3.83	7.67	1.10	1.10	0.55	0.00	2.19	0.00	0.00
Sebocyte, donor2	11301-117B5	45.50	1.38	3.68	0.46	0.00	0.00	1.84	0.00	0.00	0.00
Sebocyte, donor3	11378-118B1	27.00	4.33	2.06	0.41	0.82	0.21	0.21	0.41	0.41	0.41
Sertoli Cells, donor1	11255-116F4	14.91	1.66	1.66	1.66	1.66	0.00	0.00	1.66	1.66	0.00
Sertoli Cells, donor2	11333-117F1	11.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	29.82	3.61	1.76	0.26	1.41	0.18	0.44	0.88	0.44	0.00
Skeletal Muscle Cells, donor2	11358-117H8	17.35	2.17	0.72	0.00	0.72	1.45	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	94.47	3.34	6.69	0.00	0.84	0.00	0.84	0.84	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	32.20	2.51	2.04	0.94	0.94	0.16	0.00	0.31	0.00	0.16
Skeletal Muscle Cells, donor5	11455-119A6	32.26	4.31	2.68	1.19	0.45	0.15	0.59	0.30	0.45	0.30
Skeletal Muscle Cells, donor6	11459-119B1	45.09	2.46	3.85	0.92	0.92	0.46	0.62	0.62	0.00	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	25.20	6.17	2.77	0.25	1.51	0.50	0.25	0.63	0.13	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	28.40	8.70	2.43	0.86	2.00	0.57	0.57	0.00	0.14	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	56.25	4.86	4.17	1.59	0.89	0.50	0.79	0.30	0.00	0.10
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	37.91	3.79	2.19	0.42	0.93	0.76	0.34	0.25	0.17	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	31.12	2.90	2.90	0.00	0.00	0.00	0.00	0.72	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	26.42	3.16	2.06	0.41	0.96	0.00	0.69	0.28	0.00	0.00
Skin - palm, donor1	10286-104F7	37.61	2.69	5.37	2.69	0.00	0.00	2.69	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	24.22	1.15	2.74	0.58	0.29	0.00	0.29	0.14	0.29	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	78.52	5.73	7.36	1.64	0.82	0.00	0.82	0.00	0.82	1.64
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	24.80	1.82	1.30	0.26	0.65	0.00	0.00	0.39	0.00	0.26
Small Airway Epithelial Cells, donor1	11256-116F5	16.96	2.50	0.70	0.14	0.56	0.00	0.14	0.56	0.42	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	25.18	3.24	3.66	0.56	0.14	0.00	0.42	0.00	0.42	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	72.10	4.86	12.90	2.75	0.85	0.00	0.42	0.42	0.21	0.42
Small Airway Epithelial Cells, donor3	11406-118E2	19.94	3.30	2.32	0.60	0.22	0.15	0.07	0.30	0.52	0.30
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	10.80	0.93	2.16	0.00	0.31	0.00	0.00	0.00	0.31	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	34.68	2.00	2.45	0.44	0.67	0.44	0.00	0.00	0.44	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	31.74	0.00	4.11	0.59	2.35	0.00	0.59	0.59	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	30.72	1.33	2.43	0.88	0.44	0.00	0.44	0.66	0.22	0.00
Smooth Muscle Cells - Aortic, donor2	11360-117I1	29.93	2.36	1.58	1.18	1.58	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	29.36	3.86	2.32	0.00	0.77	0.00	0.00	0.77	0.00	0.77
Smooth Muscle Cells - Bladder, donor1	11519-119H7	14.01	1.00	0.00	0.00	1.00	1.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	22.89	1.33	2.40	0.27	0.53	0.13	0.40	0.40	0.27	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	20.84	1.77	1.11	0.22	0.66	0.00	0.22	0.00	0.00	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	11.91	0.90	1.02	0.64	0.26	0.13	0.00	0.13	0.13	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	18.56	2.60	1.30	0.65	0.00	1.63	0.33	0.00	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	22.15	2.07	2.36	0.00	0.89	0.30	0.00	0.30	0.00	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	21.78	1.42	2.28	0.71	0.00	0.00	0.28	0.14	0.00	0.14
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	39.53	5.04	3.90	0.65	0.49	0.00	0.00	0.49	0.16	0.16
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	17.35	2.44	0.30	0.30	0.00	0.30	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	35.11	2.78	1.52	1.52	0.51	0.00	0.00	0.25	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	42.84	6.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	17.64	0.95	0.48	0.48	0.00	0.00	0.48	0.00	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	16.07	1.03	1.33	0.00	0.00	0.29	0.15	0.00	0.29	0.15
Smooth Muscle Cells - Colonic, donor2	11320-117D6	23.68	2.15	1.94	0.00	0.00	0.43	1.08	0.22	0.22	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	25.19	3.88	2.83	0.73	0.63	0.00	0.42	0.31	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	33.87	3.56	3.71	0.46	0.93	0.31	0.00	0.31	0.15	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	26.95	2.16	1.08	0.00	2.16	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	25.70	1.49	2.09	0.60	0.00	0.30	0.00	0.30	0.00	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	44.38	5.80	3.41	0.00	0.68	0.00	0.34	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	16.73	2.43	1.02	0.16	1.96	0.63	0.39	0.16	0.08	0.24
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	20.93	5.64	1.11	0.70	1.61	0.50	0.60	1.11	0.50	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	16.16	1.82	0.68	1.14	0.23	0.00	0.91	0.23	0.00	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	13.89	2.42	1.21	1.81	1.21	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	46.36	4.50	6.36	1.59	0.26	0.53	0.53	0.00	0.53	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	19.31	2.13	1.46	0.67	0.53	0.00	0.00	0.53	0.00	0.00
Smooth Muscle Cells - Prostate, donor2	11335-117F3	23.79	3.01	1.38	0.38	0.75	0.25	1.00	0.00	0.13	0.00
Smooth Muscle Cells - Prostate, donor3	11465-119B7	5.83	1.52	0.25	0.25	0.25	0.00	0.00	0.51	0.00	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	33.62	4.07	0.90	0.75	0.60	0.90	0.15	0.60	0.15	0.00
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	27.01	1.50	0.00	1.50	0.00	0.00	0.00	0.75	0.00	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	67.20	2.58	2.58	0.00	3.88	1.29	0.00	1.29	2.58	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	52.55	6.05	4.65	0.93	0.93	0.00	0.47	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	17.67	1.01	2.02	0.00	1.01	1.01	0.50	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	13.79	2.51	1.25	0.00	0.31	0.00	0.94	0.00	0.00	0.31
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	25.37	3.83	2.95	1.18	0.29	0.29	0.00	0.88	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	33.82	3.17	3.75	1.08	0.58	0.17	0.00	0.08	0.00	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	15.42	1.40	1.40	0.47	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	24.18	2.01	2.30	0.43	1.15	0.43	0.14	0.14	0.29	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	30.59	2.80	3.06	0.25	0.51	0.25	0.51	0.76	0.00	0.00
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	28.02	0.75	1.32	0.19	0.19	0.19	0.94	0.19	0.00	0.38
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	33.12	3.63	3.21	0.56	0.56	0.00	0.14	0.14	0.00	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	20.44	2.60	2.51	0.84	0.59	0.08	0.00	0.00	0.00	0.08
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	13.33	5.24	1.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	24.47	1.22	2.45	0.49	0.49	0.24	0.98	0.49	0.00	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	17.90	2.21	1.33	0.88	0.66	0.00	0.22	0.00	0.00	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	19.02	1.76	0.88	0.59	0.29	0.29	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	11.86	0.97	0.39	0.00	1.17	0.39	0.19	0.58	0.19	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	12.43	1.06	0.26	0.00	0.26	0.00	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	12.27	0.00	0.37	0.00	0.37	0.00	0.74	0.00	0.00	0.37
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	17.25	1.80	0.00	0.00	0.72	0.36	0.00	0.00	0.36	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	22.14	1.14	0.57	0.00	1.14	0.00	0.28	0.28	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	24.42	1.58	1.97	0.00	0.79	0.39	1.18	0.39	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	10.67	0.76	0.00	0.25	0.25	0.00	0.76	0.51	0.25	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	8.79	2.80	1.20	0.80	0.80	0.00	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	8.78	1.25	1.25	0.42	1.25	0.00	1.67	0.42	0.00	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	10.08	2.29	0.00	0.00	0.92	0.00	0.00	0.00	0.00	0.92
Synoviocyte, donor1	11291-117A4	12.79	2.19	0.67	0.17	0.84	0.17	0.50	0.00	0.00	0.17
Synoviocyte, donor2	11368-117I9	8.55	2.01	1.17	0.50	0.50	0.17	0.17	0.17	0.00	0.17
Synoviocyte, donor3	11440-118H9	7.15	1.34	1.34	0.22	1.12	0.22	0.22	0.22	0.00	0.45
Trabecular Meshwork Cells, donor1	11532-120A2	88.62	5.36	4.65	2.50	3.57	0.71	1.79	1.07	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	25.77	3.96	1.98	1.98	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	53.95	4.17	4.17	0.93	1.62	0.69	0.46	0.00	0.46	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	23.08	2.44	1.65	0.43	0.00	0.00	0.07	0.14	0.22	0.07
Tracheal Epithelial Cells, donor2	11369-118A1	27.06	3.87	1.93	1.16	0.00	0.00	0.77	0.00	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	18.90	0.57	1.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	14.39	7.75	2.09	0.98	1.60	0.12	0.37	0.00	0.12	0.12
Urethra, donor2	10319-105A4	48.56	3.60	0.00	0.00	3.60	1.80	0.00	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	45.16	1.86	3.72	0.80	0.80	0.27	0.27	0.27	0.27	0.00
Urothelial Cells, donor2	11600-120H7	22.03	2.40	1.60	0.00	0.00	0.00	0.80	0.40	0.40	0.00
Urothelial Cells, donor3	11681-122H7	28.42	4.13	5.27	0.23	0.00	0.23	0.46	0.92	0.00	0.00
Urothelial cells, donor0	11216-116B1	23.18	3.79	3.12	1.34	0.00	0.00	0.22	0.00	0.00	0.22
Whole blood (ribopure), donor090309, donation1	12179-129A1	5.34	7.12	0.89	0.89	0.00	0.00	0.89	0.00	0.00	4.45
Whole blood (ribopure), donor090309, donation2	12180-129A2	17.16	8.58	2.86	0.00	0.00	1.43	0.00	0.00	0.00	4.29
Whole blood (ribopure), donor090309, donation3	12181-129A3	8.21	8.90	2.05	0.68	0.00	0.00	0.68	0.00	0.00	2.74
Whole blood (ribopure), donor090325, donation1	12176-128I7	13.77	6.89	1.03	1.38	0.34	0.00	0.00	0.00	0.00	0.69
Whole blood (ribopure), donor090325, donation2	12177-128I8	11.62	5.81	1.16	1.74	0.58	0.00	0.58	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	13.54	9.37	1.04	1.04	1.04	0.00	0.00	0.00	0.00	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	7.34	4.59	1.84	0.00	0.92	0.00	0.00	0.00	0.00	1.84
Whole blood (ribopure), donor090612, donation3	12184-129A6	5.48	7.30	0.00	0.00	0.00	0.00	0.91	0.00	0.00	1.83
Wilms' tumor cell line:G-401	10809-111A8	102.64	4.56	6.17	0.99	2.71	1.36	0.86	0.99	0.12	0.25
Wilms' tumor cell line:HFWT	10597-108E3	62.48	1.76	7.04	0.00	0.88	0.00	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	49.44	12.01	9.22	1.68	0.00	0.00	0.56	0.00	0.00	0.00
achilles tendon, donor2	10292-104G4	10.33	2.07	2.07	4.13	0.00	0.00	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	101.73	4.08	8.41	0.76	1.78	1.53	3.06	0.76	0.00	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	149.29	3.71	14.16	0.70	2.79	1.16	1.63	1.16	0.23	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	138.65	3.44	8.43	0.47	1.54	0.83	1.42	0.71	0.24	0.24
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	135.51	4.08	8.44	1.09	1.63	1.63	1.90	0.82	0.00	0.27
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	80.95	3.65	5.90	0.56	4.50	0.28	2.53	0.28	0.56	0.28
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	40.60	7.40	4.44	0.63	1.48	0.00	0.21	0.63	0.21	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	55.80	14.97	2.99	0.27	1.91	0.27	1.09	1.36	0.00	0.27
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	63.01	0.00	3.08	0.88	1.32	0.88	0.00	1.32	0.00	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	76.77	4.49	5.31	0.41	2.45	0.41	2.04	1.23	0.00	0.41
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	74.94	6.21	7.77	1.55	5.05	3.11	0.78	0.00	0.00	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	67.34	5.52	6.44	1.66	1.10	0.37	0.92	0.37	0.00	0.37
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	156.02	19.50	0.00	7.80	0.00	0.00	0.00	0.00	3.90	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	69.48	4.88	8.37	1.39	2.32	0.46	2.56	1.16	0.00	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	173.46	8.80	8.03	2.59	1.29	0.52	2.85	2.07	0.52	0.52
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	100.53	7.01	5.84	1.46	0.58	0.29	0.58	2.05	0.00	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	38.11	6.04	1.86	0.00	3.25	0.00	0.46	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	57.16	3.70	4.52	0.82	1.23	0.00	2.47	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	88.71	5.53	4.91	0.92	3.68	0.61	0.00	0.00	0.61	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	49.92	2.56	7.68	0.43	2.13	0.00	0.85	0.43	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	54.90	4.85	4.55	0.30	2.12	0.61	0.00	0.30	0.00	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	56.33	6.26	5.30	1.20	4.09	0.48	0.24	1.20	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	41.43	5.12	4.01	0.22	1.78	0.67	1.56	0.22	0.22	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	43.69	14.01	3.34	0.67	1.33	1.33	0.67	1.33	0.33	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	542.60	55.75	61.32	7.43	9.29	5.57	9.29	1.86	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	389.09	45.95	28.63	5.27	3.77	1.13	8.29	2.64	1.13	1.13
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	101.62	15.26	6.98	3.05	5.67	0.87	0.87	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	414.26	31.87	29.99	3.75	1.87	0.00	3.75	0.00	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	40.74	2.59	3.53	0.47	1.88	0.00	0.47	0.47	0.00	0.00
adipose tissue, adult, pool1	10010-101C1	12.41	6.05	0.93	0.62	1.24	0.00	0.31	0.47	0.78	0.16
adipose, donor1	10184-103D4	61.57	2.35	9.97	0.00	1.76	0.59	5.28	3.52	5.28	0.00
adipose, donor2	10185-103D5	88.00	0.81	7.30	1.22	1.62	0.81	0.41	4.06	5.68	0.00
adipose, donor3	10186-103D6	78.42	3.27	5.45	0.27	2.72	1.91	0.54	3.54	3.54	0.27
adipose, donor4	10187-103D7	63.27	5.20	3.47	0.00	3.47	2.60	3.47	1.73	0.87	1.73
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	9.47	1.74	1.58	0.16	0.00	0.00	0.16	0.00	0.00	0.16
adrenal gland, adult, pool1	10081-102A9	14.55	3.64	0.00	3.64	7.28	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	39.76	17.48	7.47	1.60	1.07	0.27	0.00	0.67	0.27	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	55.74	1.43	3.22	0.36	0.00	0.00	0.36	0.36	0.36	0.00
amniotic membrane cells, donor1	12235-129G3	12.06	11.13	1.85	1.39	0.23	0.00	0.23	0.23	0.00	0.00
amniotic membrane cells, donor2	12236-129G4	12.17	9.47	3.38	1.35	0.34	0.00	0.00	0.00	0.34	0.00
amniotic membrane cells, donor3	12237-129G5	6.78	11.78	2.06	1.18	0.29	0.00	0.29	0.29	0.00	0.59
amygdala - adult, donor10196	10167-103B5	40.32	11.86	4.74	1.19	1.19	2.37	4.74	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	33.46	9.12	5.68	0.61	4.66	0.61	2.23	0.41	0.00	0.41
amygdala, newborn, donor10223	10360-105E9	41.96	6.13	1.61	0.00	0.65	0.65	0.65	0.32	0.32	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	23.56	3.06	1.91	0.38	1.66	0.13	0.13	0.00	0.25	0.25
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	47.43	7.06	7.06	1.10	0.88	0.22	0.66	0.00	0.22	0.00
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	141.63	7.68	5.34	1.34	14.70	6.35	1.34	0.33	0.33	0.33
aorta, adult, pool1	10052-101G7	16.48	3.92	1.57	0.20	0.59	0.20	0.20	0.00	0.00	0.20
appendix, adult	10189-103D9	48.13	12.42	1.94	0.39	3.49	0.78	0.00	0.78	0.39	0.39
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	50.56	6.53	2.06	0.00	2.06	0.69	1.03	0.00	0.34	0.00
artery, adult	10190-103E1	17.66	8.15	2.72	0.00	2.72	0.00	0.00	0.00	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	17.82	3.48	3.48	0.43	1.16	0.72	0.00	0.00	0.00	0.14
b cell line:RPMI1788	10427-106D4	30.63	4.16	3.12	0.59	1.34	2.23	0.00	0.15	0.15	0.15
basal cell carcinoma cell line:TE 354.T	10702-109G9	15.81	2.50	2.50	0.28	0.00	0.28	0.28	0.00	0.00	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	30.46	6.15	2.58	0.60	0.40	0.00	0.00	0.69	0.10	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	11.05	3.01	2.18	1.51	0.17	0.00	0.00	0.17	0.00	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	59.84	11.18	3.36	1.68	0.56	0.00	1.12	0.56	0.00	0.00
bladder, adult, pool1	10011-101C2	15.97	5.87	2.39	0.65	2.28	0.11	0.11	0.98	0.22	0.22
blood, adult, pool1	10053-101G8	19.93	6.64	2.21	0.00	0.00	0.00	0.00	0.00	0.00	2.21
bone marrow stromal cell line:StromaNKtert	10686-109F2	21.41	3.43	0.86	1.71	4.28	0.86	0.00	0.00	0.00	0.00
bone marrow, adult	10192-103E3	16.87	4.72	1.35	0.67	0.67	0.67	2.02	1.35	0.67	0.67
brain, adult, donor1	10084-102B3	33.83	6.15	7.18	0.00	4.10	0.00	1.03	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	28.73	11.80	5.01	2.45	4.34	0.67	0.22	0.56	0.56	0.11
brain, fetal, pool1	10085-102B4	149.60	18.70	0.00	0.00	5.34	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	57.15	24.12	6.28	1.98	0.00	0.00	1.98	0.33	0.00	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	31.33	15.98	4.74	1.37	0.37	0.00	0.00	0.00	0.00	0.00
breast, adult, donor1	10080-102A8	7.58	3.16	1.26	1.89	0.00	0.63	0.63	0.00	0.00	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	30.74	6.61	4.19	1.14	0.25	0.13	0.76	0.38	0.25	0.76
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	48.86	3.40	5.26	0.93	0.00	0.31	0.93	0.31	0.00	0.00
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	19.11	2.07	0.92	0.23	0.00	0.00	0.46	0.00	0.23	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	27.84	7.02	3.39	0.97	1.45	0.00	0.00	0.48	0.24	0.24
carcinoid cell line:NCI-H1770	10703-109H1	74.29	9.87	10.81	3.29	4.23	0.47	0.47	1.41	0.47	0.94
carcinoid cell line:NCI-H727	10735-110B6	78.75	23.74	7.33	2.95	1.20	0.11	0.22	0.33	0.44	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	81.13	3.17	9.19	0.63	0.63	0.32	1.58	0.95	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	101.68	9.32	5.86	0.80	2.93	0.53	3.73	1.33	0.53	0.00
caudate nucleus - adult, donor10196	10177-103C6	26.48	4.61	0.00	0.00	4.61	0.00	1.15	0.00	1.15	0.00
caudate nucleus, adult, donor10252	10164-103B2	28.78	9.70	5.35	0.84	4.52	0.67	1.34	0.33	0.00	0.00
caudate nucleus, adult, donor10258	10379-105H1	29.80	4.58	0.76	0.76	3.82	0.76	0.76	0.00	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	42.85	3.66	1.46	0.37	1.10	0.00	1.10	0.37	0.00	0.37
cerebellum - adult, donor10196	10173-103C2	58.27	20.39	5.83	2.91	5.83	2.91	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	61.92	25.62	12.17	2.99	2.35	0.43	2.56	0.43	0.43	0.21
cerebellum, adult, pool1	10083-102B2	33.11	6.55	3.79	2.41	1.38	0.00	1.03	0.00	0.69	0.00
cerebellum, newborn, donor10223	10357-105E6	88.84	7.47	1.66	1.66	2.49	0.00	0.83	0.00	0.00	2.49
cerebral meninges, adult	10188-103D8	20.68	8.82	4.29	1.26	3.03	1.01	0.50	0.25	0.25	0.00
cerebrospinal fluid, donor2	10294-104G6	12.43	4.39	0.73	0.00	0.00	0.00	2.19	0.73	0.00	0.73
cervical cancer cell line:D98-AH2	10552-107I3	23.87	4.31	2.59	1.01	0.86	0.29	0.14	0.14	0.00	0.00
cervical cancer cell line:ME-180	10553-107I4	31.98	6.30	3.48	1.16	0.33	0.33	0.17	0.17	0.17	0.00
cervix, adult, pool1	10013-101C4	23.73	8.71	2.41	0.73	1.78	0.31	0.21	0.63	0.21	0.10
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	24.52	3.34	2.23	0.56	0.84	0.00	0.00	0.00	0.00	0.00
chondrosarcoma cell line:SW 1353	10700-109G7	24.82	2.61	1.31	0.00	1.31	0.00	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	42.88	7.21	4.47	0.99	1.12	0.25	0.50	1.12	1.24	0.25
choriocarcinoma cell line:SCH	10785-110H2	17.87	3.82	3.57	0.37	0.99	0.49	0.12	0.12	0.00	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	15.42	4.74	3.32	0.00	0.24	0.00	0.24	0.00	0.24	0.00
chorionic membrane cells, donor1	12238-129G6	6.84	5.13	2.56	0.57	0.28	0.00	0.00	0.00	0.00	0.28
chorionic membrane cells, donor2	12239-129G7	29.73	3.28	5.67	1.39	0.70	0.10	0.40	1.19	0.40	0.00
chorionic membrane cells, donor3	12240-129G8	8.79	2.75	2.20	0.55	1.65	0.00	1.10	0.00	0.55	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	30.29	2.02	1.01	0.00	1.01	2.02	0.00	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	59.55	4.99	4.03	1.73	1.34	0.58	0.00	0.00	0.00	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	93.77	8.45	8.24	2.96	1.06	1.06	0.21	0.21	0.21	0.21
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	84.74	3.34	10.02	1.28	1.03	0.00	1.28	0.00	0.00	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	79.58	3.63	10.16	1.69	0.97	0.48	1.21	0.00	0.24	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	72.69	4.28	7.33	1.63	0.61	0.41	2.85	0.61	0.00	0.20
chronic myelogenous leukemia cell line:K562	10454-106G4	88.93	2.06	8.83	1.18	0.59	0.00	0.88	0.00	0.00	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	147.25	10.69	9.64	2.09	1.30	1.30	1.30	1.04	0.00	0.00
clear cell carcinoma cell line:JHOC-5	10638-108I8	3.43	0.23	0.23	0.23	0.00	0.00	0.00	0.00	0.00	0.46
clear cell carcinoma cell line:TEN	10636-108I6	32.10	6.77	3.64	0.87	0.52	0.17	0.69	0.00	0.17	0.00
colon carcinoma cell line:CACO-2	10513-107D9	48.69	1.83	5.13	0.73	0.55	0.18	0.18	0.18	0.18	0.18
colon carcinoma cell line:COLO-320	10420-106C6	81.34	4.56	6.46	0.00	7.98	1.52	0.00	0.76	0.00	0.76
colon, adult, donor1	10082-102B1	36.89	7.14	2.38	0.00	3.57	0.00	0.00	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	17.98	9.87	1.18	1.29	1.29	0.00	0.35	0.35	0.12	0.24
colon, fetal, donor1	10070-101I7	16.69	3.09	1.24	0.00	1.24	0.62	0.00	0.00	0.62	0.00
common myeloid progenitor CMP, donor1	12130-128D6	316.26	64.17	22.92	0.00	18.33	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	42.92	1.70	1.27	0.85	0.42	0.00	0.00	0.85	0.00	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	40.60	3.47	1.96	0.91	0.45	0.45	0.60	0.75	0.15	0.15
cord blood derived cell line:COBL-a untreated	10449-106F8	47.80	2.68	1.41	0.42	0.42	1.13	0.28	0.56	0.14	0.14
corpus callosum, adult, pool1	10042-101F6	36.04	16.25	5.42	1.66	7.96	0.44	0.22	0.11	0.22	0.22
cruciate ligament, donor2	10295-104G7	21.07	3.24	3.24	0.00	1.62	0.81	0.81	0.81	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	22.47	9.63	0.80	0.00	1.61	0.00	0.00	0.00	0.00	0.00
diencephalon, adult	10193-103E4	19.44	6.24	2.40	0.24	3.36	0.24	0.48	0.00	0.48	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	90.24	4.82	5.05	2.07	1.38	1.15	2.76	1.84	0.46	0.92
ductal cell carcinoma cell line:KLM-1	10438-106E6	23.59	7.95	1.80	0.26	0.00	0.00	0.26	0.00	0.00	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	25.52	2.65	1.93	0.96	0.72	0.48	0.72	0.96	0.24	0.00
ductus deferens, adult	10196-103E7	15.95	6.98	0.50	1.00	4.98	0.50	0.50	1.00	0.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	17.28	7.20	0.00	0.00	1.44	0.00	0.00	0.00	1.44	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	30.90	17.66	2.21	0.00	0.00	0.00	0.74	0.74	1.47	0.74
dura mater, adult, donor1	10041-101F5	30.89	9.83	3.22	0.58	0.41	0.33	0.17	0.08	0.41	0.41
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	73.73	13.77	5.11	1.78	2.00	1.11	0.44	2.66	2.44	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	75.80	8.17	3.44	1.43	0.57	0.14	0.14	1.29	0.72	0.29
embryonic pancreas cell line:1B2C6	10604-108F1	1.85	0.00	0.00	0.62	0.00	0.00	0.00	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	3.94	0.00	0.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	6.17	0.31	0.62	0.31	0.00	0.00	0.00	0.00	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	11.82	0.00	1.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	52.96	1.68	3.69	0.67	0.00	0.67	0.34	0.34	0.00	0.00
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	13.41	0.91	1.45	0.00	0.00	0.00	0.00	0.36	0.00	0.00
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	39.88	3.86	3.70	0.64	0.80	0.00	0.96	0.32	0.00	0.16
epidermoid carcinoma cell line:A431	10426-106D3	24.45	6.67	2.45	0.78	0.78	0.11	0.00	0.00	0.11	0.11
epidermoid carcinoma cell line:Ca Ski	10431-106D8	48.94	6.05	3.96	0.55	0.11	0.22	0.11	0.44	0.00	0.00
epididymis, adult	10197-103E8	17.58	5.65	1.88	0.21	3.14	0.63	0.21	0.21	0.00	0.42
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	32.64	2.48	3.02	0.89	3.19	0.00	0.71	0.00	0.00	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	38.54	1.57	2.36	0.00	0.00	0.00	0.79	0.00	0.39	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	42.46	6.81	9.57	0.79	0.92	0.00	1.05	0.52	0.00	0.66
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	37.89	6.59	8.37	0.98	0.98	0.10	1.38	0.59	0.30	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	40.67	6.95	12.32	1.57	0.78	0.22	2.24	0.90	0.22	0.78
esophagus, adult, pool1	10015-101C6	29.73	8.92	3.40	0.85	1.59	0.11	0.00	0.74	0.53	0.42
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	87.92	2.50	6.76	0.75	1.00	0.00	0.25	0.63	0.88	0.38
eye - muscle inferior rectus, donor1	10272-104E2	14.49	2.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	10.52	0.00	2.10	0.00	8.42	0.00	4.21	0.00	2.10	0.00
eye - muscle medial, donor2	10299-104H2	20.84	4.46	1.49	0.00	10.42	0.00	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	35.54	2.29	0.00	0.00	3.44	1.15	1.15	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	30.61	7.29	4.37	1.46	1.46	1.46	0.00	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	22.37	5.08	2.03	0.25	1.27	0.00	1.02	0.00	0.25	0.00
fibrosarcoma cell line:HT-1080	10758-110E2	30.39	2.31	2.82	0.77	2.05	0.13	0.64	0.26	0.26	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	26.83	4.51	3.80	0.47	0.47	0.47	0.47	0.00	0.00	0.24
frontal lobe, adult, pool1	10040-101F4	42.31	17.55	6.66	1.69	5.82	0.75	0.47	0.19	0.19	0.00
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	61.55	3.00	3.60	1.20	0.00	0.00	0.90	0.00	0.00	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	36.12	3.57	2.47	0.37	0.37	0.09	0.00	0.18	0.00	0.18
gall bladder, adult	10198-103E9	23.18	7.48	1.93	0.72	2.90	0.97	0.48	0.24	0.00	0.00
gamma delta positive T cells, donor1	11937-126A2	11.81	9.13	1.61	1.07	0.00	0.00	0.00	0.00	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	8.59	10.46	2.24	0.00	0.00	0.00	0.00	0.37	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	31.26	13.31	3.59	0.63	0.84	0.00	1.90	1.06	0.21	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	58.80	13.73	8.90	1.74	1.35	0.00	1.16	0.00	0.00	0.00
gastric cancer cell line:AZ521	10549-107H9	9.67	0.49	0.49	0.00	0.16	0.33	0.00	0.00	0.00	0.00
gastric cancer cell line:GSS	10560-108A2	33.86	2.75	3.66	0.00	0.00	0.00	0.92	0.92	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	42.04	10.74	6.17	2.28	1.37	0.23	0.69	1.14	0.46	0.00
giant cell carcinoma cell line:LU65	10487-107B1	16.52	2.07	0.80	0.34	0.11	0.00	0.80	0.34	0.00	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	28.41	5.32	2.66	0.00	0.56	0.00	0.28	0.28	0.00	0.28
glassy cell carcinoma cell line:HOKUG	10688-109F4	14.22	3.24	2.99	0.25	0.50	0.00	0.00	0.00	0.25	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	77.26	7.28	5.17	0.95	0.84	0.11	0.53	0.21	0.00	0.11
glioblastoma cell line:A172, tech_rep2	10444-106F3	72.89	8.15	6.88	1.83	1.83	0.42	0.70	0.14	0.28	0.00
glioblastoma cell line:T98G	10485-107A8	34.88	5.08	2.32	0.55	1.66	0.22	0.66	0.00	0.00	0.11
glioma cell line:GI-1	10413-106B8	53.60	2.93	4.69	0.59	2.05	0.29	0.29	1.17	0.88	0.00
globus pallidus - adult, donor10196	10175-103C4	17.49	5.83	1.46	0.00	3.64	0.00	2.19	0.00	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	28.56	10.98	6.59	0.24	6.83	0.00	1.95	0.24	0.00	0.00
globus pallidus, adult, donor10258	10367-105F7	21.91	6.85	1.37	0.00	4.11	0.00	0.00	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	32.51	3.73	1.07	0.53	2.13	0.00	1.07	0.00	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	371.97	58.73	29.37	14.68	17.13	2.45	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	10.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	15.68	0.00	5.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	31.36	2.56	2.24	0.96	0.96	0.32	0.96	0.00	0.00	0.00
hIPS +CCl2, biol_rep1	14383-156B9	54.18	5.51	4.59	0.00	0.92	0.46	1.38	0.92	0.46	0.46
hIPS +CCl2, biol_rep2	14384-156C1	51.21	7.32	2.74	0.46	0.91	1.37	0.91	0.00	0.46	0.91
hIPS +CCl2, biol_rep3	14385-156C2	50.24	2.58	3.22	1.29	0.00	1.93	0.64	0.64	0.00	0.00
hIPS, biol_rep1	14380-156B6	18.68	0.00	2.87	0.00	1.44	1.44	1.44	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	33.61	2.74	2.06	0.00	2.06	2.06	0.00	0.69	0.00	0.00
hIPS, biol_rep3	14382-156B8	30.90	6.62	6.62	0.00	4.41	1.10	2.21	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	60.63	5.75	2.59	1.15	1.15	0.29	0.29	0.29	0.29	0.00
heart - mitral valve, adult	10205-103F7	16.74	5.08	1.49	0.90	1.20	0.60	0.00	0.30	0.00	0.00
heart - pulmonic valve, adult	10206-103F8	14.64	10.72	0.78	0.26	2.88	0.52	0.26	0.00	0.00	0.00
heart - tricuspid valve, adult	10207-103F9	45.80	5.83	1.67	0.00	0.83	0.00	0.00	0.00	0.00	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	8.98	6.53	1.02	0.61	1.02	0.00	0.82	0.20	0.00	0.41
heart, adult, diseased, donor1	10051-101G6	11.07	9.37	2.13	0.43	4.68	0.00	2.13	0.00	0.00	0.00
heart, adult, pool1	10016-101C7	9.43	8.51	1.84	0.69	2.07	0.00	0.00	0.00	0.00	1.61
heart, fetal, pool1	10046-101G1	24.44	10.06	2.77	0.51	3.08	0.72	0.10	0.00	0.21	0.00
hepatic mesenchymal tumor cell line:LI90	10778-110G4	22.52	1.85	2.16	0.00	0.62	0.00	0.00	0.31	0.62	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	42.81	8.32	3.57	0.00	3.57	0.00	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	63.09	6.85	10.39	1.33	1.55	1.10	1.44	0.55	0.11	0.11
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	58.99	5.95	10.07	0.97	0.85	0.85	1.46	0.97	0.12	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	63.06	7.07	8.08	0.71	2.22	0.71	1.72	0.91	0.00	0.20
hepatoma cell line:Li-7	10484-107A7	21.13	1.22	2.22	0.33	0.67	0.11	0.44	0.22	0.00	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	64.02	8.74	6.03	1.01	0.80	0.90	0.70	0.10	0.00	0.00
hippocampus - adult, donor10196	10169-103B7	26.50	4.73	1.89	0.95	1.89	0.00	0.95	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	31.64	11.23	5.92	0.61	2.65	0.20	2.65	0.82	0.61	0.41
hippocampus, adult, donor10258	10374-105G5	23.40	5.98	4.48	0.50	4.48	0.50	1.00	0.00	0.00	0.50
hippocampus, newborn, donor10223	10363-105F3	37.72	5.29	0.00	0.70	1.41	0.70	0.00	0.35	1.06	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	70.80	4.88	3.66	1.22	0.61	2.44	4.27	0.61	2.44	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	77.95	5.11	3.53	0.59	0.79	0.98	1.37	0.39	1.37	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	81.75	4.06	2.79	0.51	1.52	2.79	1.52	3.30	1.78	0.51
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	107.70	2.82	8.46	0.56	4.51	0.56	1.13	4.51	6.77	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	131.17	4.13	5.68	1.03	4.13	2.07	6.71	9.81	7.75	0.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	117.68	4.93	3.80	0.76	3.80	1.52	1.14	4.18	6.83	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	110.36	3.21	7.59	0.58	4.96	1.75	1.75	3.80	5.26	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	121.07	6.03	7.54	1.51	4.09	2.15	1.51	9.69	6.03	0.22
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	96.34	2.50	7.92	0.00	3.75	1.67	0.42	2.92	3.34	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	81.69	3.08	1.42	0.71	1.42	0.71	0.24	3.55	0.71	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	124.72	4.18	4.98	0.48	4.98	2.41	1.61	3.86	1.77	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	84.84	4.71	9.43	0.00	2.02	0.00	0.67	4.71	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	89.51	5.63	6.57	1.25	2.19	1.56	1.72	1.10	1.41	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	84.50	3.44	4.42	0.98	1.97	0.98	2.95	1.47	3.44	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	57.60	2.62	1.75	0.00	0.87	2.62	4.36	0.87	1.75	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	150.63	3.44	6.87	2.29	3.82	1.34	1.34	5.92	5.92	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	133.44	1.74	5.67	1.31	4.36	0.87	1.31	5.23	6.54	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	114.95	4.50	3.50	0.00	1.50	2.00	1.50	4.00	7.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	92.12	3.77	5.27	0.38	2.83	1.88	0.57	4.52	3.01	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	90.03	4.09	6.37	0.91	2.73	0.91	1.36	7.28	1.82	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	86.45	3.13	3.76	0.94	2.51	1.57	1.25	4.39	4.07	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	93.90	3.10	2.78	0.49	3.43	2.29	1.14	2.61	1.63	0.33
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	91.16	0.87	3.19	0.29	1.16	0.87	1.45	2.61	1.74	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	92.07	4.78	2.39	0.90	4.18	2.69	1.79	3.59	2.69	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	74.64	4.80	5.17	0.55	1.11	1.66	1.85	0.74	1.48	0.74
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	81.88	4.28	6.85	0.00	1.43	0.86	1.14	1.71	1.43	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	91.87	4.90	6.53	0.41	0.82	1.22	0.82	0.82	0.82	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	112.31	5.28	6.34	1.41	1.76	2.11	2.46	4.22	3.52	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	109.91	4.12	4.43	0.00	3.80	1.27	0.63	5.38	2.85	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	103.50	2.72	3.33	0.61	1.51	1.82	0.30	3.33	5.14	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	81.19	4.65	5.17	0.52	1.03	1.55	0.52	2.59	2.07	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	79.70	3.32	3.32	0.66	3.98	1.33	1.33	1.99	1.99	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	78.76	3.08	2.82	1.54	3.08	1.28	0.77	2.31	2.31	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	86.92	4.35	3.83	1.02	1.79	2.81	1.02	3.32	1.53	0.26
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	81.78	2.27	3.03	0.76	2.27	1.51	2.27	3.03	2.27	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	71.24	2.02	1.68	0.34	1.68	1.68	0.67	3.36	1.68	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	85.98	5.55	5.07	1.93	2.17	2.42	1.21	0.97	1.45	0.48
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	85.12	5.35	1.78	0.00	1.34	1.78	2.67	3.12	2.23	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	84.88	7.32	4.39	1.46	1.46	1.46	0.98	0.49	0.98	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	163.20	3.97	7.33	0.61	0.92	1.22	0.92	4.58	9.17	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	48.80	0.00	3.25	0.00	6.51	0.00	6.51	6.51	26.03	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	109.87	5.96	3.97	0.99	1.99	1.32	2.65	4.96	13.57	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	102.89	4.93	5.47	1.09	1.09	3.28	1.64	6.02	3.83	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	91.19	2.90	3.98	1.45	2.90	1.09	2.17	1.45	3.62	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	76.87	1.42	2.49	0.00	1.78	1.42	1.42	3.56	3.20	0.36
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	70.41	2.39	4.77	0.00	2.39	1.19	2.39	3.58	2.39	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	128.65	4.88	7.04	0.41	2.44	2.84	0.81	5.82	3.93	0.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	78.93	2.16	2.16	0.81	1.89	2.16	1.35	3.23	2.96	0.00
immature langerhans cells, donor1	11904-125F5	13.32	6.30	0.73	0.24	0.73	0.00	0.00	0.24	0.00	0.00
immature langerhans cells, donor2	11905-125F6	22.18	5.54	2.38	0.79	0.00	0.00	0.00	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	54.60	18.07	7.57	1.61	6.15	1.32	0.38	0.66	0.28	0.00
keratoacanthoma cell line:HKA-1	10791-110H8	11.38	1.63	1.95	0.00	0.65	0.00	0.00	0.33	0.65	0.00
kidney, adult, pool1	10017-101C8	23.13	10.71	2.00	0.90	1.40	0.20	0.40	0.40	0.10	0.10
kidney, fetal, pool1	10045-101F9	59.06	15.63	3.75	1.34	2.26	1.41	0.21	0.42	0.14	0.14
large cell lung carcinoma cell line:IA-LM	10509-107D5	31.53	8.52	4.69	0.43	0.71	0.43	0.14	0.43	0.28	0.28
large cell lung carcinoma cell line:NCI-H460	10839-111E2	14.10	1.11	1.80	0.28	0.83	0.00	0.14	0.28	0.14	0.41
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	13.76	2.57	2.20	0.18	0.73	0.18	0.55	0.00	0.00	0.00
left atrium, adult, donor1	10079-102A7	7.08	4.36	1.63	0.00	1.63	0.00	0.54	0.00	0.54	0.54
left ventricle, adult, donor1	10078-102A6	4.55	4.05	0.51	0.51	0.51	0.00	0.00	0.00	0.00	0.51
leiomyoblastoma cell line:G-402	10721-110A1	91.93	2.74	8.76	1.37	0.82	0.27	0.27	0.00	0.27	0.00
leiomyoma cell line:10964C	10569-108B2	13.29	0.72	0.72	0.00	0.00	1.08	0.72	0.36	0.36	0.00
leiomyoma cell line:15242A	10570-108B3	14.67	1.09	1.09	0.54	0.54	0.00	0.54	0.00	0.00	0.00
leiomyoma cell line:15425	10571-108B4	17.24	2.43	1.46	0.49	0.00	0.24	0.00	0.00	0.00	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	12.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	64.82	5.23	3.14	2.09	1.05	0.00	0.00	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	98.34	12.40	10.03	2.01	0.12	0.24	1.18	0.35	0.24	0.24
liposarcoma cell line:KMLS-1	10782-110G8	23.28	1.41	1.09	0.16	0.31	0.16	0.16	0.16	0.00	0.16
liposarcoma cell line:SW 872	10726-110A6	33.14	3.78	5.73	0.73	1.95	0.49	0.37	0.24	0.00	0.24
liver, adult, pool1	10018-101C9	11.18	6.97	1.62	0.97	1.13	0.00	0.16	0.32	0.49	0.16
liver, fetal, pool1	10086-102B5	11.29	2.82	0.00	0.00	1.88	0.00	0.94	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	20.85	10.06	3.06	1.17	4.81	0.73	1.17	0.00	0.15	0.15
locus coeruleus, adult, donor10252	10165-103B3	23.07	9.78	5.17	0.92	3.32	1.11	1.11	0.37	0.18	0.37
locus coeruleus, adult, donor10258	10375-105G6	26.24	6.49	1.97	0.85	5.36	1.41	0.28	0.28	0.28	0.28
locus coeruleus, newborn, donor10223	10362-105F2	21.03	3.79	2.10	1.68	0.42	0.42	0.42	1.26	1.26	0.00
lung adenocarcinoma cell line:A549	10499-107C4	1.52	0.14	0.14	0.00	0.00	0.00	0.00	0.00	0.00	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	39.30	10.34	6.20	1.38	0.00	0.00	0.00	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	66.44	1.85	3.69	0.79	0.26	0.00	0.26	0.13	0.53	0.13
lung, adult, pool1	10019-101D1	16.77	8.62	2.95	0.35	0.71	0.24	0.12	0.71	0.47	0.12
lung, fetal, donor1	10068-101I5	46.52	8.56	0.86	1.14	0.29	0.86	0.29	1.14	0.57	0.00
lung, right lower lobe, adult, donor1	10075-102A3	21.08	5.50	1.37	0.46	0.46	0.46	0.00	0.46	0.46	0.46
lymph node, adult, donor1	10077-102A5	23.19	3.79	1.42	1.42	0.47	0.00	0.47	0.47	0.00	0.00
lymphangiectasia cell line:DS-1	10727-110A7	17.53	13.81	5.48	2.41	0.88	0.22	0.88	0.00	0.22	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	48.30	3.47	5.74	1.66	0.91	1.21	0.15	0.45	0.15	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	66.26	15.29	3.40	2.55	1.70	0.00	0.00	0.00	1.70	0.85
mature adipocyte, donor1	12231-129F8	11.54	9.32	2.66	0.00	0.89	0.00	0.00	0.44	0.00	0.00
mature adipocyte, donor2	12232-129F9	9.55	5.81	1.04	0.42	0.62	0.00	0.00	0.00	0.00	0.21
mature adipocyte, donor3	12233-129G1	6.40	4.74	1.19	0.71	1.42	0.24	0.00	0.00	0.24	0.00
mature adipocyte, donor4	12234-129G2	3.42	3.16	1.05	0.26	1.32	0.00	0.26	0.00	0.00	0.26
maxillary sinus tumor cell line:HSQ-89	10414-106B9	16.44	5.96	1.91	0.71	0.24	0.24	0.00	0.00	0.24	0.24
medial frontal gyrus - adult, donor10196	10170-103B8	29.33	13.54	4.51	0.00	3.38	1.13	2.26	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	27.59	15.45	6.07	0.74	6.07	0.55	2.57	0.18	0.18	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	25.73	8.26	2.86	0.64	2.86	0.64	0.64	0.00	0.00	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	25.16	5.54	2.99	0.00	1.71	1.71	1.71	0.00	0.00	0.85
medial temporal gyrus - adult, donor10196	10183-103D3	32.40	12.83	5.23	2.03	5.06	1.69	5.06	1.01	0.51	0.51
medial temporal gyrus, adult, donor10252	10156-103A3	28.01	9.97	7.00	1.27	3.61	1.06	2.76	0.42	0.00	0.42
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	15.41	5.78	3.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	28.71
medial temporal gyrus, newborn, donor10223	10353-105E2	43.79	3.95	2.15	0.36	2.51	1.08	0.72	0.00	0.36	0.00
medulla oblongata - adult, donor10196	10174-103C3	14.28	5.19	3.24	0.65	4.54	0.00	1.95	0.00	0.00	0.65
medulla oblongata, adult, donor10252	10155-103A2	17.03	13.62	5.11	0.77	4.02	0.93	1.39	0.15	0.15	0.15
medulla oblongata, adult, pool1	10038-101F2	35.10	14.37	5.14	0.82	5.71	0.82	0.24	0.65	0.16	0.00
medulla oblongata, newborn, donor10223	10361-105F1	22.22	5.21	1.39	0.35	2.43	0.00	0.69	0.35	0.35	0.00
medulloblastoma cell line:D283 Med	10838-111E1	210.12	5.98	10.63	1.77	3.76	0.00	4.87	2.21	0.22	0.44
medulloblastoma cell line:ONS-76	10759-110E3	99.65	5.14	8.31	0.24	6.11	0.49	0.73	0.24	0.61	0.24
melanoma cell line:COLO 679	10514-107E1	29.04	3.31	2.16	0.00	1.87	0.43	0.14	1.15	1.15	0.00
melanoma cell line:G-361	10465-106H6	36.38	1.63	1.90	0.27	5.16	0.81	1.09	0.27	0.54	0.27
meningioma cell line:HKBMM	10691-109F7	12.84	3.08	1.63	0.54	0.36	0.18	1.09	0.18	0.00	0.54
merkel cell carcinoma cell line:MKL-1	10843-111E6	151.56	14.10	7.93	0.88	8.81	0.88	7.93	1.76	0.88	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	182.23	8.55	7.00	0.78	1.30	1.30	2.85	2.07	0.00	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	20.25	2.61	2.92	0.77	0.77	0.31	0.61	0.31	0.00	0.15
mesenchymal precursor cell - adipose, donor2	11748-123G2	12.00	1.82	1.45	0.55	0.36	0.18	0.18	0.00	0.00	0.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	16.56	1.24	0.83	0.41	0.00	0.00	0.41	0.00	0.00	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	8.43	1.69	2.25	0.14	0.56	0.00	0.28	0.00	0.00	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	8.67	1.54	2.12	0.39	0.77	0.00	0.58	0.00	0.00	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	7.63	0.69	1.39	0.00	0.69	0.00	0.00	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	4.98	2.57	1.20	0.17	0.51	0.00	0.17	0.00	0.00	0.00
mesenchymal precursor cell - cardiac, donor2	11753-123G7	16.10	2.42	2.42	0.69	0.46	0.12	0.35	0.35	0.00	0.00
mesenchymal precursor cell - cardiac, donor3	11754-123G8	16.98	1.06	2.52	0.40	0.27	0.00	0.27	0.13	0.00	0.27
mesenchymal precursor cell - cardiac, donor4	11755-123G9	17.02	2.03	1.35	0.14	0.27	0.41	0.81	0.14	0.27	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	20.20	1.71	3.27	1.14	0.28	0.14	1.28	0.00	0.00	0.28
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	10.87	1.32	1.65	0.99	0.00	0.00	0.00	0.33	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	22.14	2.77	1.94	0.55	0.55	0.28	0.28	0.00	0.00	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	20.25	1.75	1.05	0.00	0.00	0.70	0.35	0.35	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	12.45	1.43	2.65	0.61	0.20	0.00	0.20	0.20	0.00	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	16.89	1.44	2.88	0.36	0.00	0.36	0.00	0.36	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	11.59	1.76	1.76	0.62	0.41	0.10	0.00	0.00	0.10	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	14.82	1.14	1.82	0.23	0.00	0.00	0.00	0.23	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	23.91	0.84	2.10	0.42	0.42	0.42	1.26	0.00	0.42	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	15.69	1.34	1.79	0.75	0.60	0.15	0.30	0.45	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	12.69	2.45	2.19	0.61	1.14	0.18	0.44	0.18	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	18.04	0.74	1.47	0.00	0.37	0.00	0.37	0.37	0.37	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	29.47	2.86	3.15	0.57	0.29	0.00	0.86	0.00	0.29	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	40.42	1.68	1.68	0.42	1.26	0.00	0.84	0.84	0.00	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	10.96	2.28	1.83	0.91	0.00	0.00	0.46	0.46	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	16.37	2.30	1.79	1.02	0.26	0.00	0.51	0.51	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	16.75	2.09	2.36	0.26	0.00	0.00	0.52	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	15.40	4.01	1.23	0.00	0.31	0.00	0.00	0.92	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	12.24	2.59	0.94	0.24	0.71	0.47	0.71	0.94	0.00	0.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	14.22	1.69	1.02	0.00	0.68	0.34	0.68	0.34	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	14.54	2.36	1.18	0.79	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	14.83	2.78	0.46	0.00	0.46	0.00	0.00	0.00	0.46	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	48.30	48.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	14.71	2.31	1.44	0.29	0.58	0.58	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	14.95	3.57	2.01	0.22	0.00	0.22	0.22	0.22	0.22	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	15.86	2.16	1.44	0.00	0.48	0.48	0.00	0.24	1.20	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	21.27	1.47	0.00	0.00	0.00	0.73	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	13.76	1.68	1.34	0.34	0.00	0.34	0.00	0.34	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	11.46	2.05	1.23	0.00	0.00	0.41	0.82	0.41	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	14.18	2.58	2.15	0.00	0.43	0.00	0.00	0.43	0.00	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	13.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	15.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	12.34	2.27	0.65	0.32	0.32	0.65	0.00	0.00	0.32	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	7.27	2.91	1.45	0.00	2.91	0.00	0.00	1.45	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	13.33	3.73	1.60	1.07	0.00	0.00	1.07	0.00	1.07	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	15.54	0.00	0.82	0.00	1.64	0.00	0.00	0.82	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	14.38	1.55	1.55	0.00	0.00	0.00	0.00	0.39	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	14.69	0.00	2.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	11.92	0.00	1.99	0.00	0.99	0.99	0.00	0.00	0.99	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	11.27	2.96	0.59	0.00	1.19	0.00	0.59	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	12.18	2.44	0.00	0.00	2.44	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00	0.00	0.00	27.05	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	9.50	1.27	1.27	1.27	0.00	0.00	0.00	0.00	0.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	9.66	1.03	0.00	1.03	0.34	0.34	0.34	0.69	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	12.90	2.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	10.33	0.00	0.00	0.00	3.44	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	8.56	1.63	0.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	6.36	0.79	0.00	0.00	0.79	0.79	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	10.02	0.59	1.18	0.00	0.59	0.00	0.00	0.00	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	8.42	0.62	0.31	0.31	0.31	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	6.68	1.34	1.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	20.11	0.00	2.37	0.00	0.00	0.00	0.00	0.00	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	10.27	0.00	2.57	0.00	0.00	0.00	0.00	2.57	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	16.52	0.69	1.38	0.00	0.00	0.00	0.69	2.07	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	13.36	1.98	0.49	0.00	1.48	0.49	0.99	0.00	0.49	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	6.73	1.12	0.00	1.12	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	13.36	0.64	1.91	0.00	0.64	0.64	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	10.48	0.40	0.81	0.00	0.81	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	10.90	2.18	0.00	0.00	0.00	0.00	2.18	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	7.60	1.27	0.00	0.00	3.80	0.00	1.27	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	5.46	1.21	1.21	0.00	1.21	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	4.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	2.47	1.65	1.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	7.94	0.99	1.19	0.20	0.60	0.00	0.00	0.20	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	9.73	0.32	1.62	0.32	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	10.19	2.04	3.06	0.00	1.02	0.00	0.00	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	23.99	7.74	6.19	0.77	2.32	0.00	0.77	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	33.55	8.03	2.83	0.24	1.42	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	44.71	4.63	3.01	0.70	2.09	1.39	0.70	0.46	0.23	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	21.37	8.55	0.00	0.00	4.27	0.00	0.00	4.27	4.27	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	24.04	1.54	2.16	0.31	0.72	0.00	0.21	0.31	0.51	0.00
mesothelioma cell line:Mero-25	10850-111F4	25.42	6.13	0.91	0.23	0.68	0.23	0.45	0.00	0.00	0.23
mesothelioma cell line:Mero-41	10851-111F5	45.47	6.60	3.67	0.98	1.22	0.00	0.49	0.49	0.00	0.00
mesothelioma cell line:Mero-48a	10852-111F6	20.15	5.54	1.77	0.22	1.77	0.22	0.22	0.22	0.00	0.00
mesothelioma cell line:Mero-82	10853-111F7	29.96	2.10	1.58	0.00	1.31	0.53	1.31	0.26	0.00	0.00
mesothelioma cell line:Mero-83	10854-111F8	46.81	4.43	3.92	0.34	0.68	0.34	1.02	0.51	1.02	0.00
mesothelioma cell line:Mero-84	10855-111F9	6.57	14.66	3.03	2.02	0.25	0.00	1.01	0.51	0.76	0.25
mesothelioma cell line:Mero-95	10856-111G1	28.16	2.28	1.66	0.21	4.76	0.83	1.45	1.45	0.62	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	25.51	2.48	0.99	0.33	0.66	0.17	0.50	0.17	0.17	0.17
mesothelioma cell line:NCI-H226	10846-111E9	24.25	1.63	0.90	0.18	0.36	0.36	0.36	0.18	0.00	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	28.36	4.27	1.71	0.51	1.37	0.17	0.68	0.00	0.17	0.17
mesothelioma cell line:NCI-H28	10845-111E8	46.57	4.33	4.07	0.76	0.25	0.00	0.25	0.00	0.25	0.00
mesothelioma cell line:No36	10857-111G2	51.21	6.52	4.57	0.98	1.96	0.33	0.65	0.33	0.33	0.33
mesothelioma cell line:ONE58	10858-111G3	13.28	2.44	0.27	0.27	0.81	0.00	0.27	0.27	0.00	0.27
migratory langerhans cells, donor1	11901-125F2	30.52	7.87	2.49	0.58	0.00	0.00	0.38	0.77	0.00	0.00
migratory langerhans cells, donor2	11902-125F3	21.61	10.01	0.98	0.73	0.37	0.00	0.24	0.37	0.00	0.00
migratory langerhans cells, donor3	11903-125F4	16.69	9.69	0.90	0.90	0.18	0.36	0.00	0.18	0.18	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	17.63	2.94	1.96	0.00	1.31	0.00	2.61	0.00	0.00	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	12.08	1.91	1.91	0.42	0.21	0.21	0.64	0.21	0.21	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	40.77	5.99	2.99	0.00	0.46	0.00	0.00	0.00	0.00	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	27.02	1.52	2.66	0.57	0.95	0.00	0.38	0.19	0.19	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	74.66	4.80	6.84	1.29	3.33	0.74	0.00	0.92	0.18	0.37
myeloma cell line:PCM6	10474-106I6	25.30	2.77	2.17	0.59	1.38	0.59	0.20	0.00	0.00	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	40.08	5.07	2.03	0.51	0.00	0.00	0.51	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	40.60	2.35	3.33	0.59	1.37	0.20	0.59	0.59	0.00	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	8.69	4.12	2.01	0.45	0.11	0.00	0.00	0.00	0.00	0.11
nasal epithelial cells, donor1, tech_rep2	12226-129F3	5.81	4.04	1.10	0.88	0.07	0.00	0.00	0.00	0.07	0.22
nasal epithelial cells, donor2	12227-129F4	19.32	4.42	1.10	0.55	0.55	0.00	0.55	0.00	0.00	0.55
neuroblastoma cell line:CHP-134	10508-107D4	230.75	13.57	12.88	2.30	12.88	4.37	1.38	0.23	0.46	0.00
neuroblastoma cell line:NB-1	10539-107G8	150.04	14.59	15.53	3.18	4.86	3.18	0.56	1.50	0.19	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	75.29	5.48	5.69	0.84	4.22	3.59	1.05	0.42	0.21	0.21
neuroblastoma cell line:NH-12	10555-107I6	185.79	9.88	13.04	0.93	6.89	2.80	0.93	0.56	0.93	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	107.23	3.08	5.22	0.24	1.66	0.47	3.80	0.71	0.00	0.47
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	73.49	7.92	6.65	0.79	1.43	0.79	3.17	1.58	0.32	0.00
neuroectodermal tumor cell line:TASK1	10774-110F9	118.54	5.64	7.45	1.01	2.62	0.40	0.40	0.40	0.00	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	210.44	6.99	13.99	0.00	1.27	0.64	0.00	0.64	1.27	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	23.42	2.40	1.33	0.27	0.80	0.00	0.00	0.00	0.27	0.27
neutrophil PMN, donor1	12133-128D9	178.50	163.62	14.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	26.56	0.00	0.00	13.28	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	18.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	160.66	4.74	13.19	1.18	8.79	7.44	1.01	1.01	0.17	0.17
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	33.62	12.81	4.80	0.80	3.20	1.60	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	15.39	1.28	2.89	0.32	1.28	0.96	0.32	0.00	0.00	0.00
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	23.91	2.36	1.31	0.00	1.05	0.00	1.05	0.53	0.00	0.00
nucleus accumbens, adult, pool1	10037-101F1	43.21	15.84	5.91	1.87	4.97	0.47	0.28	1.12	0.09	0.28
occipital cortex - adult, donor10196	10172-103C1	39.15	14.42	6.18	0.00	8.24	6.18	0.00	2.06	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	32.74	13.42	5.37	0.54	4.83	0.27	1.88	0.27	1.07	0.27
occipital cortex, newborn, donor10223	10355-105E4	56.78	3.64	2.55	0.00	1.46	0.00	0.36	0.00	0.36	0.00
occipital lobe, adult, donor1	10076-102A4	32.01	7.87	4.99	1.31	4.20	0.52	1.31	0.52	0.52	0.00
occipital lobe, fetal, donor1	10073-102A1	181.08	9.87	9.01	3.86	0.86	3.00	4.72	1.72	1.29	0.00
occipital pole, adult, pool1	10036-101E9	42.97	14.03	7.57	1.66	6.23	1.26	0.32	0.79	0.00	0.08
olfactory region, adult	10195-103E6	26.37	11.65	6.30	2.10	3.06	0.19	0.76	0.57	0.00	0.00
optic nerve, donor1	10277-104E7	28.01	8.00	2.00	2.00	4.00	0.00	2.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	43.40	21.30	6.04	2.39	0.34	0.11	0.46	0.80	0.57	0.34
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	78.31	4.40	4.40	0.27	0.82	0.14	0.27	0.41	0.14	0.14
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	15.75	2.37	0.85	0.17	0.17	0.00	0.68	0.00	0.17	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	18.48	4.27	3.58	0.81	0.23	0.00	0.58	0.23	0.00	0.23
osteoclastoma cell line:Hs 706.T	10704-109H2	15.87	6.17	1.76	0.59	0.29	0.00	0.00	0.00	0.00	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	75.68	14.95	11.21	1.87	0.93	0.93	0.00	0.00	0.00	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	38.38	14.00	4.24	1.06	1.70	0.21	0.21	0.21	0.42	0.00
ovary, adult, pool1	10020-101D2	22.97	8.65	2.88	0.52	2.18	0.26	0.09	0.52	0.44	0.35
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	33.36	5.68	4.03	0.92	0.92	0.18	0.18	0.00	0.00	0.00
pancreas, adult, donor1	10049-101G4	15.05	10.35	4.70	0.00	2.82	0.00	0.00	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	19.85	5.03	1.96	1.12	0.28	0.00	0.00	0.00	0.28	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	25.04	2.21	1.70	0.51	0.85	0.17	1.02	0.68	0.17	0.34
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	31.63	5.13	1.32	1.16	0.33	0.17	0.00	0.33	0.33	0.00
paracentral gyrus, adult, pool1	10035-101E8	37.71	16.02	5.40	1.46	5.03	0.64	0.37	0.09	0.09	0.00
parietal cortex, adult, donor10258	10373-105G4	31.56	7.34	2.20	0.00	0.73	0.00	0.00	0.00	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	22.57	10.35	6.58	0.00	4.70	0.00	0.94	0.00	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	28.50	10.83	7.70	2.00	4.56	0.29	1.14	0.29	0.29	0.29
parietal lobe, adult, pool1	10034-101E7	42.56	17.18	6.52	2.64	5.20	0.53	0.62	0.26	0.00	0.00
parietal lobe, fetal, donor1	10072-101I9	160.99	13.58	8.73	0.97	0.97	0.97	6.79	3.88	0.00	0.97
parietal lobe, newborn, donor10223	10356-105E5	45.61	5.98	2.99	1.12	1.12	0.00	0.75	0.00	0.00	0.37
parotid gland, adult	10199-103F1	10.48	7.40	0.00	0.00	1.23	0.00	1.23	1.23	1.85	0.00
penis, adult	10200-103F2	15.58	4.30	0.54	0.00	2.69	0.00	1.07	0.54	0.00	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	40.72	9.11	1.49	0.74	2.05	0.56	0.93	0.74	0.37	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	21.42	5.54	2.33	0.73	0.58	0.00	0.29	0.00	0.15	0.00
pineal gland - adult, donor10196	10179-103C8	52.25	10.32	3.87	0.65	10.32	0.65	3.23	0.00	0.65	0.65
pineal gland, adult, donor10252	10160-103A7	81.73	16.58	8.29	0.59	10.66	0.00	3.55	1.78	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	36.37	6.27	2.51	1.88	7.52	0.00	1.88	0.00	0.00	0.63
pituitary gland - adult, donor10196	10180-103C9	26.31	12.14	2.02	2.02	4.05	0.00	2.02	1.01	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	30.23	13.55	3.65	1.56	3.65	2.08	1.04	0.52	1.04	1.04
pituitary gland, adult, donor10258	10378-105G9	25.54	3.40	0.85	0.85	0.85	0.00	0.00	0.00	0.00	0.00
placenta, adult, pool1	10021-101D3	16.45	14.08	3.98	0.97	0.86	0.11	0.00	0.11	0.00	0.11
plasma cell leukemia cell line:ARH-77	10840-111E3	50.32	1.99	2.91	0.79	1.06	0.53	0.53	0.26	0.13	0.13
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	9.34	7.16	1.56	0.31	0.62	0.00	0.16	0.16	0.16	0.00
pons, adult, pool1	10033-101E6	26.42	15.32	4.30	1.29	3.87	0.52	0.00	0.26	0.09	0.00
postcentral gyrus, adult, pool1	10032-101E5	41.58	17.00	6.80	1.57	5.14	1.31	0.35	0.35	0.09	0.00
promyelocytes/myelocytes PMC, donor1	12132-128D8	217.51	71.11	18.82	4.18	6.27	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	5.51	0.00	0.00	0.00	0.00	5.51	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	6.70	0.29	1.17	0.44	0.00	0.00	0.00	0.29	0.00	0.15
prostate cancer cell line:PC-3	10439-106E7	91.30	4.72	9.26	0.91	2.18	0.73	1.45	0.54	0.54	0.54
prostate, adult, pool1	10022-101D4	18.23	7.53	2.00	0.45	1.81	0.73	0.09	0.36	0.18	0.27
putamen, adult, donor10196	10176-103C5	43.44	12.28	10.86	2.12	6.61	2.60	1.89	0.47	0.47	0.24
putamen, adult, donor10252	10152-102I8	27.45	3.92	3.92	0.00	7.84	0.00	0.00	1.96	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	20.76	2.19	2.19	0.00	2.19	2.19	0.00	0.00	0.00	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	37.69	10.39	5.56	1.93	3.62	1.69	0.24	0.48	0.00	0.48
putamen, newborn, donor10223	10365-105F5	29.24	0.00	0.75	0.00	0.00	1.50	0.75	0.75	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	29.09	13.96	7.27	0.58	0.29	0.00	0.29	0.00	0.00	0.29
rectum, fetal, donor1	10067-101I4	70.94	6.95	1.39	1.39	4.17	2.78	2.78	0.00	1.39	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	22.68	3.60	1.70	0.21	0.85	0.00	0.00	0.21	0.00	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	3.73	0.41	0.41	0.00	0.41	0.00	0.41	0.00	0.00	0.41
retina, adult, pool1	10030-101E3	33.20	16.80	4.77	1.39	6.66	0.89	0.20	0.40	0.40	0.20
retinoblastoma cell line:Y79	10475-106I7	184.98	6.24	16.63	2.34	4.94	0.78	2.86	0.78	0.78	0.78
rhabdomyosarcoma cell line:KYM-1	10787-110H4	86.06	8.98	6.89	1.23	1.48	0.12	0.86	0.25	0.25	0.00
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	145.66	1.97	10.12	1.12	0.56	0.00	0.56	0.00	0.28	0.56
sacrococcigeal teratoma cell line:HTST	10695-109G2	28.04	6.06	0.76	0.00	1.52	0.00	0.00	0.00	0.00	0.76
salivary acinar cells, donor1	11771-123I7	27.68	2.75	1.62	0.65	1.13	0.32	0.49	0.32	0.16	0.49
salivary acinar cells, donor2	11772-123I8	21.89	3.58	1.79	0.28	0.41	0.00	0.96	0.41	0.28	0.41
salivary acinar cells, donor3	11773-123I9	21.85	10.59	5.96	0.66	2.65	0.00	0.66	0.00	0.00	0.00
salivary gland, adult, pool1	10093-102C3	27.45	1.72	0.57	0.57	1.14	0.57	0.00	0.00	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	23.19	2.70	2.53	0.84	2.19	0.67	0.08	0.08	0.17	0.17
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	22.33	4.58	3.53	0.24	1.53	0.35	0.35	0.12	0.24	0.12
seminal vesicle, adult	10201-103F3	17.99	4.23	2.12	0.00	3.17	0.53	1.06	0.53	0.53	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	15.30	8.75	1.46	0.73	0.24	0.00	0.73	0.00	0.24	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	16.10	7.30	2.26	0.75	0.50	0.00	0.25	0.50	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	34.12	8.03	3.01	0.00	1.00	0.00	3.01	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	34.12	1.88	1.07	0.27	0.40	0.00	0.40	0.00	0.13	0.13
signet ring carcinoma cell line:Kato III	10436-106E4	18.35	2.21	2.10	0.22	0.66	0.00	0.22	0.22	0.22	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	24.64	3.23	2.58	0.90	1.03	0.13	0.00	0.39	0.26	0.13
skeletal muscle - soleus muscle, donor1	10282-104F3	21.28	4.26	2.13	0.00	1.42	0.00	0.71	0.00	0.71	2.84
skeletal muscle, adult, pool1	10023-101D5	15.47	10.55	3.00	0.48	0.84	0.00	0.00	0.48	0.00	4.92
skeletal muscle, fetal, donor1	10066-101I3	51.26	4.02	9.05	0.00	4.02	0.00	5.03	1.01	0.00	0.00
skin, adult, donor1	10074-102A2	20.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	56.81	6.31	6.94	2.52	1.26	0.00	4.42	0.00	0.00	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	63.04	12.01	8.34	2.00	2.00	0.67	0.00	0.00	0.67	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	157.92	11.35	6.30	1.26	6.93	1.58	5.36	0.95	1.26	0.95
small cell lung carcinoma cell line:DMS 144	10841-111E4	11.95	0.00	0.77	0.00	0.19	0.00	0.19	0.00	0.00	0.19
small cell lung carcinoma cell line:LK-2	10541-107H1	82.25	3.96	2.14	1.15	1.65	2.14	0.82	0.33	0.66	0.33
small cell lung carcinoma cell line:NCI-H82	10842-111E5	77.05	9.17	9.01	0.97	1.29	0.64	1.77	0.97	0.32	0.16
small cell lung carcinoma cell line:WA-hT	10562-108A4	48.60	2.40	7.63	0.44	4.58	0.22	0.44	0.22	0.22	0.44
small intestine, adult, pool1	10024-101D6	20.66	16.12	2.99	1.19	1.55	0.12	0.24	0.84	0.48	0.00
small intestine, fetal, donor1	10064-101I1	22.11	7.62	1.97	0.49	0.74	0.74	2.70	0.25	0.00	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	53.34	24.11	2.05	1.54	0.51	0.00	1.54	2.56	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	11.89	7.24	1.55	0.78	3.88	0.00	0.26	0.52	0.00	0.00
somatostatinoma cell line:QGP-1	10781-110G7	85.50	8.31	5.09	1.61	0.00	0.00	0.54	0.27	0.27	0.27
spinal cord - adult, donor10196	10181-103D1	18.12	5.96	1.61	0.23	3.21	0.69	2.29	0.46	0.23	0.00
spinal cord, adult, donor10252	10159-103A6	18.53	7.89	3.15	1.18	2.37	0.00	0.79	0.79	0.00	0.00
spinal cord, adult, donor10258	10369-105F9	9.69	5.53	2.77	0.00	0.69	0.69	0.69	0.00	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	54.89	14.64	11.59	1.83	3.66	0.61	0.61	1.22	0.00	0.61
spinal cord, newborn, donor10223	10359-105E8	13.78	10.56	0.92	0.46	2.76	0.00	1.38	1.38	0.00	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	24.05	2.84	2.09	0.75	0.45	0.00	0.15	0.15	0.00	0.15
spleen, adult, pool1	10025-101D7	21.81	9.58	1.43	0.55	1.10	0.22	0.22	0.66	0.11	0.00
spleen, fetal, pool1	10044-101F8	41.87	12.95	3.89	1.19	1.83	0.40	0.24	0.32	0.16	0.08
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	33.02	3.42	1.76	0.62	1.04	0.72	0.21	0.41	0.10	0.10
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	23.54	4.94	3.61	0.57	0.00	0.00	0.00	0.00	0.19	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	4.19	2.80	0.70	0.00	1.05	0.00	0.35	0.00	0.00	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	31.27	8.60	3.52	0.39	0.39	0.39	0.00	0.00	0.39	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	10.81	4.50	0.45	1.13	0.68	0.34	0.11	0.23	0.23	0.00
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	49.56	4.24	3.81	1.27	3.39	0.42	0.85	0.42	0.42	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	2.54	0.00	0.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00
stomach, fetal, donor1	10062-101H8	38.45	11.75	2.14	1.07	0.00	0.00	0.00	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	15.38	5.70	1.71	1.14	1.14	0.00	1.71	1.14	0.00	0.00
substantia nigra - adult, donor10196	10178-103C7	0.00	54.27	0.00	0.00	0.00	0.00	54.27	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	17.66	6.85	4.57	1.25	5.61	0.21	0.83	0.21	0.00	0.00
substantia nigra, adult, donor10258	10371-105G2	18.10	5.69	2.59	0.00	5.17	0.52	0.52	0.00	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	30.38	3.53	1.41	1.41	2.12	0.71	0.00	0.71	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	116.01	6.65	7.80	0.69	2.75	1.60	3.44	0.23	0.00	0.23
temporal lobe, adult, pool1	10031-101E4	46.28	16.19	6.44	2.20	4.75	0.34	0.51	0.25	0.08	0.34
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	212.97	10.68	7.83	1.42	1.42	0.71	11.40	2.14	1.42	1.42
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	168.34	7.03	6.15	1.32	2.64	0.44	4.40	2.64	0.00	1.32
tenocyte, donor1	11763-123H8	23.04	3.84	3.14	1.40	1.40	0.35	1.75	0.00	0.00	0.00
tenocyte, donor2	11765-123I1	6.87	1.14	0.38	0.76	0.38	0.00	0.00	0.00	0.00	0.00
tenocyte, donor3	11768-123I4	8.90	1.11	1.11	1.11	0.74	0.00	0.00	0.00	0.00	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	87.19	4.25	4.42	0.68	1.70	2.72	1.19	0.85	0.68	0.17
teratocarcinoma cell line:NCR-G1	10798-110I6	62.89	9.25	5.09	0.46	2.47	1.08	0.77	1.54	0.92	0.15
teratocarcinoma cell line:PA-1	10807-111A6	65.56	17.20	7.44	1.55	0.93	1.70	1.24	1.24	0.15	0.15
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	40.37	8.51	3.81	1.52	0.63	0.00	0.38	0.89	0.38	0.00
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	69.96	18.53	8.70	1.13	1.13	0.38	1.13	1.13	0.00	1.51
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	49.30	35.45	5.78	2.62	0.00	0.44	1.09	1.20	0.22	0.33
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	59.60	25.40	5.54	1.95	0.00	0.98	5.21	1.30	0.98	0.33
testis, adult, pool1	10026-101D8	28.67	13.42	11.70	5.15	1.72	0.43	0.21	1.18	1.72	0.32
testis, adult, pool2	10096-102C6	48.27	15.34	22.10	9.47	1.80	0.45	5.41	0.90	2.26	0.45
thalamus - adult, donor10196	10168-103B6	25.39	6.62	2.21	1.10	5.52	0.00	1.10	1.10	0.00	0.00
thalamus, adult, donor10252	10154-103A1	23.75	12.50	3.91	0.31	6.10	0.31	1.56	0.31	0.00	0.47
thalamus, adult, donor10258, tech_rep1	10370-105G1	6.16	9.24	6.16	0.00	1.54	0.00	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	20.75	5.11	2.47	0.33	3.62	0.16	0.00	0.16	0.33	0.16
thalamus, newborn, donor10223	10366-105F6	24.74	5.18	0.00	0.00	0.00	0.58	1.15	0.00	0.58	0.00
throat, adult	10209-103G2	20.97	7.24	2.75	0.50	1.50	0.25	1.50	2.00	0.25	0.25
throat, fetal, donor1	10061-101H7	31.08	7.01	3.05	0.91	2.13	1.22	0.00	0.30	0.00	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	98.97	3.97	6.36	0.99	13.91	14.11	0.99	1.79	0.20	0.00
thymus, adult, pool1	10027-101D9	139.88	19.78	7.06	1.89	3.28	2.19	0.40	2.78	2.29	0.10
thymus, fetal, pool1	10043-101F7	133.41	13.30	10.81	1.56	3.12	2.39	0.52	1.04	0.31	0.31
thyroid carcinoma cell line:KHM-5M	10776-110G2	31.78	3.59	2.66	0.27	1.20	0.40	0.53	0.13	0.40	0.00
thyroid carcinoma cell line:TCO-1	10783-110G9	23.89	6.98	3.49	0.70	2.65	0.42	0.28	0.00	0.28	0.00
thyroid, adult, pool1	10028-101E1	13.44	9.14	1.68	0.47	3.83	0.09	0.19	0.28	0.19	0.09
thyroid, fetal, donor1	10060-101H6	26.89	10.81	1.85	1.05	2.90	0.53	1.85	0.53	0.00	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	40.04	3.08	0.00	0.00	3.08	0.00	3.08	0.00	0.00	0.00
tongue, adult	10203-103F5	17.44	3.72	1.40	0.70	0.70	0.00	1.63	0.47	0.23	0.47
tongue, fetal, donor1	10059-101H5	22.46	6.70	4.73	0.00	2.36	0.00	0.00	0.39	0.00	0.39
tonsil, adult, pool1	10047-101G2	53.79	13.92	4.11	1.80	1.70	0.60	0.10	0.60	0.00	0.00
trachea, adult, pool1	10029-101E2	23.89	8.02	2.54	1.31	1.39	0.08	0.08	0.33	0.08	0.16
trachea, fetal, donor1	10058-101H4	23.85	6.54	1.54	0.00	0.38	0.38	1.15	0.38	0.00	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	24.80	1.42	2.83	0.71	1.06	0.00	0.71	0.35	0.35	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	109.02	3.95	4.76	1.11	0.61	0.30	0.30	1.01	0.10	0.10
transitional-cell carcinoma cell line:JMSU1	10492-107B6	55.78	10.34	6.42	1.41	1.41	0.94	0.78	0.63	1.25	0.63
tridermal teratoma cell line:HGRT	10694-109G1	53.27	9.51	3.81	1.90	5.71	1.90	1.90	0.00	0.00	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	18.12	4.83	3.05	0.93	0.51	0.17	0.17	0.25	0.17	0.17
umbilical cord, fetal, donor1	10057-101H3	14.61	8.35	0.00	0.00	4.17	0.00	0.00	0.00	0.00	0.00
uterus, adult, pool1	10100-102D1	25.94	7.00	1.88	0.17	3.07	1.19	0.34	0.68	0.17	0.17
uterus, fetal, donor1	10055-101H1	34.30	5.63	4.61	0.51	0.00	1.02	2.05	1.54	0.00	0.00
vagina, adult	10204-103F6	9.05	3.88	1.94	0.65	0.65	0.00	0.00	0.00	0.00	0.00
vein, adult	10191-103E2	25.21	6.58	0.88	0.66	0.66	0.22	0.66	0.22	0.44	0.66
xeroderma pigentosum b cell line:XPL 17	10563-108A5	30.44	2.94	2.94	0.53	0.27	0.53	0.53	0.27	0.00	0.53